| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.583 | 0.005 | 0.583 | 5 Hydroxytryptamine antagonist | 0.54 0.006 DBMET02171 0.343 0.015 DBMET02180 0.361 0.014 DB12110 0.361 0.014 DBMET01878 0.468 0.008 DBMET02172 0.484 0.008 DBMET02175 0.392 0.012 DBMET02176 | ||
| 0.576 | 0.004 | 0.576 | 5 Hydroxytryptamine 1A agonist | 0.365 0.005 DBMET02171 0.156 0.01 DBMET02179 0.43 0.005 DBMET02180 0.131 0.012 DBMET02182 0.143 0.011 DB12110 0.143 0.011 DBMET01878 0.08 0.02 DBMET02169 0.481 0.004 DBMET02172 0.355 0.005 DBMET02175 0.296 0.006 DBMET02176 0.059 0.025 DBMET02177 0.054 0.027 DBMET02178 0.054 0.027 DBMET02183 0.204 0.009 DBMET02184 0.096 0.016 DBMET02173 0.067 0.023 DBMET02174 | ||
| 0.57 | 0.005 | 0.745 | Alpha adrenoreceptor antagonist | 0.717 0.004 DBMET02171 0.179 0.031 DBMET02179 0.422 0.009 DBMET02180 0.297 0.016 DB12110 0.297 0.016 DBMET01878 0.412 0.009 DBMET02172 0.745 0.004 DBMET02175 0.618 0.004 DBMET02176 0.28 0.017 DBMET02177 0.081 0.071 DBMET02178 0.081 0.071 DBMET02183 | DBMET02175 | |
| 0.566 | 0.005 | 0.566 | 5 Hydroxytryptamine 2 antagonist | 0.522 0.005 DBMET02171 0.107 0.067 DBMET02179 0.416 0.009 DBMET02180 0.327 0.014 DB12110 0.327 0.014 DBMET01878 0.451 0.008 DBMET02172 0.462 0.007 DBMET02175 0.434 0.008 DBMET02176 0.089 0.08 DBMET02177 | ||
| 0.496 | 0.005 | 0.496 | 5 Hydroxytryptamine 2A antagonist | 0.448 0.005 DBMET02171 0.079 0.06 DBMET02179 0.321 0.01 DBMET02180 0.277 0.013 DB12110 0.277 0.013 DBMET01878 0.387 0.007 DBMET02172 0.393 0.007 DBMET02175 0.337 0.009 DBMET02176 | ||
| 0.481 | 0.005 | 0.622 | Alpha 1 adrenoreceptor antagonist | 0.601 0.004 DBMET02171 0.153 0.029 DBMET02179 0.331 0.009 DBMET02180 0.262 0.014 DB12110 0.262 0.014 DBMET01878 0.396 0.007 DBMET02172 0.622 0.004 DBMET02175 0.495 0.005 DBMET02176 0.223 0.018 DBMET02177 | DBMET02175 | |
| 0.474 | 0.006 | 0.782 | Antiadrenergic | 0.698 0.004 DBMET02171 0.34 0.011 DBMET02179 0.395 0.008 DBMET02180 0.108 0.051 DBMET02182 0.33 0.012 DB12110 0.33 0.012 DBMET01878 0.322 0.012 DBMET02169 0.376 0.009 DBMET02172 0.782 0.004 DBMET02175 0.648 0.005 DBMET02176 0.577 0.005 DBMET02177 0.448 0.007 DBMET02178 0.448 0.007 DBMET02183 0.141 0.039 DBMET02184 0.08 0.071 DBMET02173 | DBMET02175 | |
| 0.472 | 0.006 | 0.782 | Adrenaline antagonist | 0.697 0.004 DBMET02171 0.339 0.011 DBMET02179 0.393 0.008 DBMET02180 0.105 0.051 DBMET02182 0.328 0.011 DB12110 0.328 0.011 DBMET01878 0.32 0.012 DBMET02169 0.374 0.009 DBMET02172 0.782 0.004 DBMET02175 0.648 0.005 DBMET02176 0.577 0.005 DBMET02177 0.448 0.006 DBMET02178 0.448 0.006 DBMET02183 0.138 0.038 DBMET02184 0.078 0.07 DBMET02173 | DBMET02175 | |
| 0.487 | 0.04 | 0.726 | Antiobesity | 0.654 0.015 DBMET02171 0.395 0.068 DBMET02180 0.502 0.037 DBMET02182 0.487 0.04 DB12110 0.487 0.04 DBMET01878 0.622 0.018 DBMET02169 0.226 0.18 DBMET02172 0.565 0.025 DBMET02175 0.583 0.023 DBMET02176 0.726 0.009 DBMET02178 0.726 0.009 DBMET02183 0.361 0.082 DBMET02184 | DBMET02183 | |
| 0.37 | 0.005 | 0.37 | 5 Hydroxytryptamine 1 agonist | 0.179 0.012 DBMET02171 0.255 0.008 DBMET02180 0.141 0.015 DB12110 0.141 0.015 DBMET01878 0.281 0.007 DBMET02172 0.141 0.015 DBMET02175 0.126 0.016 DBMET02176 0.059 0.033 DBMET02184 | ||
| 0.36 | 0.007 | 0.36 | 5 Hydroxytryptamine 1A antagonist | 0.233 0.012 DBMET02171 0.207 0.014 DBMET02180 0.204 0.014 DB12110 0.204 0.014 DBMET01878 0.327 0.008 DBMET02172 0.24 0.012 DBMET02175 0.161 0.019 DBMET02176 | ||
| 0.35 | 0.006 | 0.489 | 5 Hydroxytryptamine agonist | 0.158 0.02 DBMET02171 0.124 0.027 DBMET02179 0.225 0.012 DBMET02180 0.489 0.005 DB12110 0.489 0.005 DBMET01878 0.234 0.012 DBMET02172 0.128 0.026 DBMET02175 0.122 0.028 DBMET02176 0.066 0.05 DBMET02184 | DBMET01878 | |
| 0.337 | 0.009 | 0.337 | 5 Hydroxytryptamine 1 antagonist | 0.181 0.019 DBMET02171 0.18 0.019 DBMET02180 0.207 0.016 DB12110 0.207 0.016 DBMET01878 0.293 0.01 DBMET02172 0.172 0.02 DBMET02175 0.12 0.03 DBMET02176 | ||
| 0.333 | 0.01 | 0.377 | Dopamine antagonist | 0.133 0.029 DBMET02171 0.143 0.027 DBMET02179 0.377 0.009 DBMET02180 0.209 0.018 DB12110 0.209 0.018 DBMET01878 0.235 0.016 DBMET02172 0.162 0.024 DBMET02175 0.179 0.021 DBMET02176 | DBMET02180 | |
| 0.35 | 0.029 | 0.35 | Anticonvulsant | 0.206 0.079 DBMET02171 0.174 0.103 DBMET02182 0.28 0.046 DB12110 0.28 0.046 DBMET01878 0.272 0.049 DBMET01879 0.156 0.121 DBMET02169 0.284 0.045 DBMET02172 0.148 0.132 DBMET02184 0.159 0.119 DBMET02174 | ||
| 0.35 | 0.039 | 0.484 | Cardiotonic | 0.329 0.046 DBMET02179 0.307 0.053 DBMET02180 0.484 0.017 DBMET02182 0.336 0.043 DBMET02168 0.166 0.156 DBMET02178 0.166 0.156 DBMET02183 0.467 0.019 DBMET02184 0.173 0.147 DBMET02174 | DBMET02182 | |
| 0.314 | 0.005 | 0.314 | Dopamine D3 antagonist | 0.088 0.029 DBMET02171 0.248 0.008 DBMET02180 0.147 0.015 DB12110 0.147 0.015 DBMET01878 0.195 0.011 DBMET02172 0.089 0.028 DBMET02175 0.08 0.032 DBMET02176 | ||
| 0.31 | 0.007 | 0.31 | Dopamine D4 antagonist | 0.138 0.019 DBMET02171 0.197 0.013 DBMET02180 0.233 0.01 DB12110 0.233 0.01 DBMET01878 0.28 0.008 DBMET02172 0.134 0.019 DBMET02175 0.101 0.026 DBMET02176 | ||
| 0.304 | 0.068 | 0.315 | Spasmolytic | 0.314 0.065 DBMET02171 0.196 0.123 DBMET02179 0.272 0.082 DBMET02180 0.29 0.074 DBMET02182 0.181 0.136 DB12110 0.181 0.136 DBMET01878 0.211 0.111 DBMET02169 0.189 0.129 DBMET02172 0.315 0.064 DBMET02175 0.266 0.085 DBMET02176 0.202 0.118 DBMET02177 0.271 0.082 DBMET02178 0.271 0.082 DBMET02183 0.262 0.086 DBMET02184 0.158 0.156 DBMET02173 | DBMET02175 | |
| 0.225 | 0.005 | 0.225 | Acetylcholine M4 receptor antagonist | 0.09 0.037 DBMET02171 0.096 0.031 DBMET02179 0.106 0.024 DBMET02180 0.081 0.045 DBMET02182 0.112 0.021 DB12110 0.112 0.021 DBMET01878 0.113 0.021 DBMET02172 0.099 0.029 DBMET02184 | ||
| 0.268 | 0.052 | 0.435 | Psychostimulant | 0.225 0.068 DBMET02171 0.142 0.124 DBMET02180 0.175 0.096 DBMET02182 0.435 0.018 DB12110 0.435 0.018 DBMET01878 0.203 0.078 DBMET02172 0.174 0.097 DBMET02175 0.142 0.123 DBMET02178 0.142 0.123 DBMET02183 0.145 0.121 DBMET02184 | DBMET01878 | |
| 0.216 | 0.015 | 0.224 | Alpha 2c adrenoreceptor antagonist | 0.197 0.019 DBMET02171 0.162 0.027 DBMET02180 0.224 0.014 DB12110 0.224 0.014 DBMET01878 0.157 0.029 DBMET02172 0.157 0.029 DBMET02175 0.165 0.026 DBMET02176 | DBMET01878 | |
| 0.209 | 0.014 | 0.209 | Alpha 1b adrenoreceptor antagonist | 0.141 0.024 DBMET02171 0.131 0.026 DBMET02180 0.209 0.014 DB12110 0.209 0.014 DBMET01878 0.183 0.016 DBMET02172 0.148 0.022 DBMET02175 0.097 0.036 DBMET02176 | ||
| 0.216 | 0.024 | 0.298 | 5 Hydroxytryptamine 2B antagonist | 0.13 0.052 DBMET02171 0.158 0.038 DBMET02180 0.298 0.015 DB12110 0.298 0.015 DBMET01878 0.242 0.02 DBMET02172 0.111 0.07 DBMET02175 0.118 0.063 DBMET02176 | DBMET01878 | |
| 0.205 | 0.016 | 0.311 | 5 Hydroxytryptamine 2C antagonist | 0.085 0.056 DBMET02171 0.128 0.033 DBMET02180 0.311 0.008 DB12110 0.311 0.008 DBMET01878 0.171 0.022 DBMET02172 | DBMET01878 | |
| 0.196 | 0.009 | 0.201 | Cannabinoid receptor antagonist | 0.088 0.035 DB12110 0.088 0.035 DBMET01878 0.201 0.008 DBMET02172 | DBMET02172 | |
| 0.202 | 0.017 | 0.217 | Dopamine D2 antagonist | 0.117 0.028 DBMET02171 0.217 0.015 DBMET02180 0.178 0.019 DB12110 0.178 0.019 DBMET01878 0.207 0.016 DBMET02172 0.153 0.022 DBMET02175 0.155 0.022 DBMET02176 | DBMET02180 | |
| 0.195 | 0.013 | 0.384 | 5 Hydroxytryptamine 7 antagonist | 0.089 0.028 DBMET02171 0.119 0.022 DBMET02180 0.384 0.005 DB12110 0.384 0.005 DBMET01878 0.187 0.014 DBMET02172 0.15 0.018 DBMET02175 0.073 0.035 DBMET02176 | DBMET01878 | |
| 0.196 | 0.017 | 0.236 | Alpha 1a adrenoreceptor antagonist | 0.125 0.028 DBMET02171 0.103 0.035 DBMET02180 0.236 0.013 DB12110 0.236 0.013 DBMET01878 0.175 0.02 DBMET02172 0.13 0.027 DBMET02175 0.08 0.045 DBMET02176 | DBMET01878 | |
| 0.178 | 0.004 | 0.409 | Peroxisome proliferator-activated receptor delta antagonist | 0.053 0.009 DBMET02171 0.078 0.006 DBMET02179 0.156 0.005 DBMET02180 0.409 0.002 DBMET02182 0.032 0.025 DBMET02169 0.055 0.009 DBMET02168 0.064 0.007 DBMET02172 0.047 0.01 DBMET02175 0.05 0.009 DBMET02176 0.037 0.018 DBMET02177 0.269 0.003 DBMET02178 0.269 0.003 DBMET02183 0.301 0.003 DBMET02184 0.213 0.004 DBMET02173 0.081 0.006 DBMET02174 | DBMET02182 | |
| 0.18 | 0.024 | 0.18 | Antihistaminic | 0.084 0.072 DBMET02171 0.108 0.049 DB12110 0.108 0.049 DBMET01878 0.15 0.032 DBMET02172 | ||
| 0.23 | 0.074 | 0.32 | Cyclic AMP phosphodiesterase inhibitor | 0.215 0.083 DBMET02171 0.18 0.111 DBMET02180 0.239 0.069 DBMET02182 0.251 0.063 DB12110 0.251 0.063 DBMET01878 0.32 0.034 DBMET02169 0.307 0.039 DBMET02168 0.175 0.117 DBMET02170 0.168 0.125 DBMET02176 0.215 0.083 DBMET02178 0.215 0.083 DBMET02183 0.278 0.051 DBMET02184 0.157 0.14 DBMET02173 | DBMET02169 | |
| 0.173 | 0.024 | 0.173 | Histamine antagonist | 0.099 0.048 DB12110 0.099 0.048 DBMET01878 0.143 0.031 DBMET02172 | ||
| 0.167 | 0.02 | 0.175 | Histamine H1 receptor antagonist | 0.119 0.033 DBMET02171 0.082 0.055 DBMET02179 0.088 0.05 DBMET02180 0.115 0.034 DB12110 0.115 0.034 DBMET01878 0.105 0.039 DBMET01879 0.175 0.018 DBMET02172 0.073 0.064 DBMET02175 0.07 0.068 DBMET02176 0.089 0.049 DBMET02174 | DBMET02172 | |
| 0.144 | 0.008 | 0.17 | Cannabinoid CB1 receptor antagonist | 0.092 0.019 DB12110 0.092 0.019 DBMET01878 0.17 0.006 DBMET02172 | DBMET02172 | |
| 0.167 | 0.033 | 0.29 | Alpha 2b adrenoreceptor antagonist | 0.179 0.029 DBMET02171 0.112 0.065 DBMET02180 0.29 0.01 DB12110 0.29 0.01 DBMET01878 0.149 0.039 DBMET02172 0.155 0.036 DBMET02175 0.137 0.046 DBMET02176 | DBMET01878 | |
| 0.214 | 0.082 | 0.345 | HERG channel blocker | 0.186 0.099 DBMET02179 0.345 0.039 DB12110 0.345 0.039 DBMET01878 | DBMET01878 | |
| 0.131 | 0.011 | 0.21 | Alpha 1 adrenoreceptor agonist | 0.16 0.009 DBMET02171 0.075 0.025 DBMET02180 0.208 0.006 DB12110 0.208 0.006 DBMET01878 0.107 0.015 DBMET02172 0.21 0.006 DBMET02175 0.105 0.016 DBMET02176 | DBMET02175 | |
| 0.143 | 0.024 | 0.246 | Alpha 2a adrenoreceptor antagonist | 0.142 0.024 DBMET02171 0.093 0.04 DBMET02180 0.246 0.009 DB12110 0.246 0.009 DBMET01878 0.104 0.035 DBMET02172 0.162 0.02 DBMET02175 0.106 0.034 DBMET02176 | DBMET01878 | |
| 0.123 | 0.007 | 0.123 | Vasopressin 1 antagonist | 0.104 0.009 DBMET02171 0.054 0.014 DBMET02180 0.082 0.011 DBMET02182 0.109 0.008 DBMET02172 0.089 0.01 DBMET02175 0.055 0.014 DBMET02176 0.095 0.009 DBMET02178 0.095 0.009 DBMET02183 0.09 0.01 DBMET02184 0.073 0.012 DBMET02173 0.109 0.008 DBMET02174 | ||
| 0.257 | 0.148 | 0.583 | GABA C receptor rho-3 antagonist | 0.352 0.085 DBMET02182 0.583 0.009 DB12110 0.583 0.009 DBMET01878 0.55 0.014 DBMET01879 0.249 0.155 DBMET02169 0.373 0.074 DBMET02168 0.377 0.072 DBMET02170 0.252 0.152 DBMET02172 0.276 0.133 DBMET02178 0.276 0.133 DBMET02183 0.287 0.125 DBMET02184 0.282 0.129 DBMET02173 0.279 0.131 DBMET02174 | DBMET01878 | |
| 0.141 | 0.04 | 0.324 | 5 Hydroxytryptamine 3A agonist | 0.324 0.003 DB12110 0.324 0.003 DBMET01878 0.169 0.026 DBMET02168 0.118 0.058 DBMET02170 0.099 0.077 DBMET02172 | DBMET01878 | |
| 0.132 | 0.033 | 0.218 | Alpha 2 adrenoreceptor antagonist | 0.111 0.04 DBMET02171 0.085 0.06 DBMET02180 0.218 0.015 DB12110 0.218 0.015 DBMET01878 0.085 0.06 DBMET02172 0.111 0.041 DBMET02175 0.085 0.06 DBMET02176 | DBMET01878 | |
| 0.115 | 0.02 | 0.173 | Alpha 1d adrenoreceptor antagonist | 0.07 0.035 DBMET02171 0.065 0.038 DBMET02180 0.173 0.012 DB12110 0.173 0.012 DBMET01878 0.095 0.024 DBMET02172 0.074 0.033 DBMET02175 | DBMET01878 | |
| 0.199 | 0.105 | 0.561 | Aldehyde oxidase inhibitor | 0.172 0.122 DBMET02171 0.203 0.103 DBMET02180 0.183 0.115 DBMET02182 0.561 0.024 DB12110 0.561 0.024 DBMET01878 0.362 0.053 DBMET01879 0.238 0.087 DBMET02169 0.415 0.045 DBMET02168 0.301 0.066 DBMET02170 0.187 0.112 DBMET02175 | DBMET01878 | |
| 0.106 | 0.012 | 0.106 | Antidiuretic hormone antagonist | 0.09 0.014 DBMET02171 0.046 0.024 DBMET02180 0.054 0.021 DBMET02182 0.096 0.013 DBMET02172 0.069 0.018 DBMET02175 0.046 0.024 DBMET02176 0.062 0.019 DBMET02178 0.062 0.019 DBMET02183 0.068 0.018 DBMET02184 0.054 0.021 DBMET02173 0.091 0.014 DBMET02174 | ||
| 0.159 | 0.069 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 DB12110 0.207 0.044 DBMET01878 0.132 0.089 DBMET02169 0.168 0.063 DBMET02168 0.113 0.109 DBMET02170 0.132 0.089 DBMET02184 | DBMET01878 | |
| 0.113 | 0.023 | 0.248 | Alpha adrenoreceptor agonist | 0.149 0.016 DBMET02171 0.067 0.048 DBMET02180 0.248 0.006 DB12110 0.248 0.006 DBMET01878 0.067 0.048 DBMET02172 0.193 0.009 DBMET02175 0.099 0.028 DBMET02176 | DBMET01878 | |
| 0.189 | 0.103 | 0.301 | Potassium channel (Voltage-sensitive) blocker | 0.301 0.049 DB12110 0.301 0.049 DBMET01878 | DBMET01878 | |
| 0.103 | 0.024 | 0.214 | Dopamine D1 antagonist | 0.072 0.038 DBMET02171 0.214 0.01 DBMET02180 0.186 0.011 DB12110 0.186 0.011 DBMET01878 0.107 0.023 DBMET02172 0.107 0.023 DBMET02175 0.128 0.018 DBMET02176 | DBMET02180 | |
| 0.085 | 0.006 | 0.091 | Vasopressin 1A antagonist | 0.078 0.008 DBMET02171 0.026 0.022 DBMET02179 0.053 0.012 DBMET02180 0.081 0.007 DBMET02182 0.081 0.007 DBMET02172 0.072 0.009 DBMET02175 0.053 0.012 DBMET02176 0.084 0.007 DBMET02178 0.084 0.007 DBMET02183 0.082 0.007 DBMET02184 0.076 0.008 DBMET02173 0.091 0.005 DBMET02174 | DBMET02174 | |
| 0.088 | 0.017 | 0.272 | Dopamine D4 agonist | 0.048 0.038 DBMET02171 0.053 0.032 DBMET02180 0.272 0.005 DB12110 0.272 0.005 DBMET01878 0.082 0.019 DBMET02172 0.053 0.032 DBMET02175 | DBMET01878 | |
| 0.08 | 0.013 | 0.09 | 5 Hydroxytryptamine 4 antagonist | 0.06 0.024 DBMET02180 0.09 0.009 DB12110 0.09 0.009 DBMET01878 0.058 0.026 DBMET02172 | DBMET01878 | |
| 0.165 | 0.099 | 0.366 | Anesthetic general | 0.325 0.028 DBMET02182 0.238 0.056 DB12110 0.238 0.056 DBMET01878 0.207 0.071 DBMET01879 0.135 0.131 DBMET02168 0.137 0.128 DBMET02170 0.174 0.091 DBMET02172 0.245 0.052 DBMET02178 0.245 0.052 DBMET02183 0.352 0.023 DBMET02184 0.366 0.021 DBMET02173 0.306 0.032 DBMET02174 | DBMET02173 | |
| 0.15 | 0.085 | 0.267 | Sigma receptor agonist | 0.12 0.115 DBMET02180 0.267 0.045 DB12110 0.267 0.045 DBMET01878 0.13 0.103 DBMET02172 | DBMET01878 | |
| 0.092 | 0.027 | 0.169 | 5 Hydroxytryptamine 1B antagonist | 0.169 0.011 DB12110 0.169 0.011 DBMET01878 0.067 0.043 DBMET02172 | DBMET01878 | |
| 0.066 | 0.007 | 0.101 | Angiotensin AT2 receptor antagonist | 0.039 0.012 DBMET02179 0.055 0.009 DBMET02180 0.101 0.004 DBMET02182 0.021 0.015 DBMET02168 0.091 0.004 DBMET02184 | DBMET02182 | |
| 0.082 | 0.026 | 0.166 | Adrenaline uptake inhibitor | 0.066 0.038 DBMET02171 0.055 0.051 DBMET02180 0.166 0.008 DB12110 0.166 0.008 DBMET01878 0.071 0.034 DBMET02172 | DBMET01878 | |
| 0.066 | 0.01 | 0.105 | Vasopressin 2 antagonist | 0.083 0.008 DBMET02171 0.03 0.025 DBMET02179 0.039 0.018 DBMET02180 0.075 0.009 DBMET02182 0.08 0.008 DBMET02172 0.071 0.009 DBMET02175 0.059 0.011 DBMET02176 0.044 0.016 DBMET02177 0.104 0.005 DBMET02178 0.104 0.005 DBMET02183 0.064 0.01 DBMET02184 0.082 0.008 DBMET02173 0.105 0.005 DBMET02174 | DBMET02174 | |
| 0.101 | 0.05 | 0.105 | Phosphodiesterase 6D inhibitor | 0.096 0.06 DBMET02180 0.105 0.043 DBMET02182 | DBMET02182 | |
| 0.225 | 0.176 | 0.483 | Histamine release inhibitor | 0.279 0.135 DBMET02171 0.207 0.194 DBMET02180 0.39 0.081 DBMET02182 0.297 0.125 DB12110 0.297 0.125 DBMET01878 0.386 0.083 DBMET01879 0.475 0.038 DBMET02169 0.438 0.056 DBMET02168 0.483 0.035 DBMET02170 0.295 0.126 DBMET02172 0.225 0.176 DBMET02175 0.224 0.177 DBMET02176 0.386 0.083 DBMET02178 0.386 0.083 DBMET02183 0.261 0.147 DBMET02173 0.357 0.097 DBMET02174 | DBMET02170 | |
| 0.084 | 0.035 | 0.143 | Dopamine agonist | 0.066 0.047 DBMET02171 0.09 0.031 DBMET02180 0.143 0.016 DB12110 0.143 0.016 DBMET01878 0.075 0.04 DBMET02172 0.117 0.021 DBMET02175 0.076 0.04 DBMET02176 | DBMET01878 | |
| 0.052 | 0.004 | 0.191 | Angiotensin AT1A receptor antagonist | 0.022 0.014 DBMET02171 0.039 0.004 DBMET02179 0.041 0.004 DBMET02180 0.191 0.002 DBMET02182 0.025 0.01 DBMET02168 0.023 0.013 DBMET02172 0.03 0.006 DBMET02178 0.03 0.006 DBMET02183 0.156 0.003 DBMET02184 0.029 0.007 DBMET02173 0.031 0.006 DBMET02174 | DBMET02182 | |
| 0.08 | 0.034 | 0.278 | 5 Hydroxytryptamine uptake inhibitor | 0.058 0.048 DBMET02171 0.278 0.007 DB12110 0.278 0.007 DBMET01878 0.06 0.047 DBMET02172 | DBMET01878 | |
| 0.083 | 0.039 | 0.099 | Lipase inhibitor | 0.077 0.047 DBMET02180 0.084 0.039 DBMET02182 0.067 0.057 DBMET02172 0.099 0.028 DBMET02184 0.08 0.043 DBMET02173 | DBMET02184 | |
| 0.054 | 0.013 | 0.103 | Angiotensin AT1 receptor antagonist | 0.038 0.037 DBMET02180 0.103 0.002 DBMET02182 0.042 0.029 DBMET01879 0.056 0.009 DBMET02169 0.066 0.004 DBMET02168 0.049 0.019 DBMET02170 0.06 0.006 DBMET02178 0.06 0.006 DBMET02183 0.087 0.003 DBMET02184 0.056 0.01 DBMET02173 0.062 0.005 DBMET02174 | DBMET02182 | |
| 0.06 | 0.021 | 0.101 | Dopamine D2 agonist | 0.054 0.024 DBMET02171 0.069 0.017 DBMET02180 0.06 0.021 DB12110 0.06 0.021 DBMET01878 0.052 0.025 DBMET02172 0.101 0.01 DBMET02175 0.063 0.02 DBMET02176 | DBMET02175 | |
| 0.055 | 0.016 | 0.09 | Dopamine D3 agonist | 0.044 0.024 DBMET02171 0.055 0.016 DBMET02180 0.09 0.008 DB12110 0.09 0.008 DBMET01878 0.05 0.019 DBMET02172 0.058 0.015 DBMET02175 0.048 0.02 DBMET02176 | DBMET01878 | |
| 0.058 | 0.02 | 0.084 | Dopamine D5 antagonist | 0.051 0.024 DBMET02171 0.084 0.011 DBMET02180 0.053 0.023 DB12110 0.053 0.023 DBMET01878 0.051 0.024 DBMET02172 0.056 0.022 DBMET02175 0.074 0.014 DBMET02176 | DBMET02180 | |
| 0.042 | 0.005 | 0.052 | Vasopressin 1A agonist | 0.04 0.005 DBMET02171 0.038 0.006 DBMET02179 0.038 0.006 DBMET02180 0.052 0.003 DBMET02182 0.041 0.005 DBMET02172 0.038 0.006 DBMET02175 0.037 0.007 DBMET02176 0.036 0.008 DBMET02177 0.049 0.004 DBMET02178 0.049 0.004 DBMET02183 0.048 0.004 DBMET02184 0.046 0.004 DBMET02173 0.049 0.004 DBMET02174 | DBMET02182 | |
| 0.073 | 0.038 | 0.157 | 5 Hydroxytryptamine 3A antagonist | 0.157 0.005 DB12110 0.157 0.005 DBMET01878 | DBMET01878 | |
| 0.278 | 0.243 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.282 0.238 DBMET02182 0.477 0.045 DB12110 0.477 0.045 DBMET01878 0.312 0.197 DBMET01879 0.365 0.134 DBMET02169 0.373 0.126 DBMET02168 0.368 0.131 DBMET02170 0.266 0.262 DBMET02172 | DBMET01878 | |
| 0.208 | 0.175 | 0.208 | Ca(v)3.3 blocker | |||
| 0.064 | 0.033 | 0.073 | Phosphodiesterase 1A inhibitor | 0.058 0.047 DBMET02182 0.06 0.04 DB12110 0.06 0.04 DBMET01878 0.073 0.021 DBMET02168 0.058 0.045 DBMET02184 | DBMET02168 | |
| 0.07 | 0.039 | 0.115 | MDM2 inhibitor | 0.07 0.039 DBMET02182 0.115 0.004 DB12110 0.115 0.004 DBMET01878 0.08 0.02 DBMET01879 0.067 0.047 DBMET02172 0.077 0.024 DBMET02174 | DBMET01878 | |
| 0.063 | 0.035 | 0.13 | Dopamine uptake inhibitor | 0.053 0.046 DBMET02171 0.13 0.013 DB12110 0.13 0.013 DBMET01878 0.061 0.037 DBMET02172 | DBMET01878 | |
| 0.076 | 0.048 | 0.093 | Phosphodiesterase VI inhibitor | 0.093 0.025 DBMET02180 0.075 0.051 DBMET02182 0.076 0.049 DBMET02184 | DBMET02180 | |
| 0.065 | 0.038 | 0.071 | Phosphodiesterase 1C inhibitor | 0.063 0.041 DBMET02182 0.059 0.05 DB12110 0.059 0.05 DBMET01878 0.071 0.028 DBMET02168 | DBMET02168 | |
| 0.064 | 0.038 | 0.124 | Corticotropin releasing factor 2 receptor antagonist | 0.124 0.004 DB12110 0.124 0.004 DBMET01878 0.057 0.052 DBMET02168 | DBMET01878 | |
| 0.039 | 0.015 | 0.123 | Angiotensin II receptor antagonist | 0.123 0.002 DBMET02182 0.031 0.03 DBMET01879 0.044 0.01 DBMET02169 0.064 0.004 DBMET02168 0.035 0.022 DBMET02170 0.052 0.006 DBMET02178 0.052 0.006 DBMET02183 0.105 0.003 DBMET02184 0.043 0.011 DBMET02173 0.057 0.005 DBMET02174 | DBMET02182 | |
| 0.072 | 0.048 | 0.315 | 5 Hydroxytryptamine 1F antagonist | 0.315 0.005 DB12110 0.315 0.005 DBMET01878 | DBMET01878 | |
| 0.065 | 0.042 | 0.228 | 5 Hydroxytryptamine 2A agonist | 0.228 0.004 DB12110 0.228 0.004 DBMET01878 | DBMET01878 | |
| 0.145 | 0.124 | 0.149 | P-glycoprotein inhibitor | 0.145 0.125 DBMET02171 0.139 0.134 DBMET02180 0.149 0.118 DBMET02172 0.138 0.135 DBMET02175 0.138 0.135 DBMET02184 0.144 0.127 DBMET02173 | DBMET02172 | |
| 0.03 | 0.014 | 0.034 | Antidiuretic hormone agonist | 0.027 0.019 DBMET02171 0.026 0.021 DBMET02180 0.034 0.01 DBMET02182 0.028 0.017 DBMET02172 0.03 0.014 DBMET02178 0.03 0.014 DBMET02183 0.031 0.013 DBMET02184 0.028 0.017 DBMET02173 0.031 0.013 DBMET02174 | DBMET02182 | |
| 0.199 | 0.186 | 0.231 | Beta lactamase inhibitor | 0.231 0.166 DBMET02184 | DBMET02184 | |
| 0.043 | 0.031 | 0.124 | NMDA receptor subunit 3B antagonist | 0.055 0.022 DBMET02180 0.065 0.017 DBMET02182 0.124 0.008 DB12110 0.124 0.008 DBMET01878 | DBMET01878 | |
| 0.06 | 0.049 | 0.136 | 5 Hydroxytryptamine 1D antagonist | 0.136 0.014 DB12110 0.136 0.014 DBMET01878 | DBMET01878 | |
| 0.029 | 0.017 | 0.032 | DNA polymerase III inhibitor | 0.028 0.02 DBMET02182 0.032 0.012 DBMET02168 0.028 0.018 DBMET02184 | DBMET02168 | |
| 0.019 | 0.009 | 0.023 | Vasopressin 2 agonist | 0.016 0.013 DBMET02171 0.015 0.014 DBMET02180 0.023 0.007 DBMET02182 0.017 0.011 DBMET02172 0.019 0.009 DBMET02178 0.019 0.009 DBMET02183 0.02 0.008 DBMET02184 0.018 0.01 DBMET02173 0.02 0.008 DBMET02174 | DBMET02182 | |
| 0.022 | 0.014 | 0.027 | Vasopressin 1 agonist | 0.021 0.018 DBMET02171 0.02 0.019 DBMET02180 0.027 0.008 DBMET02182 0.021 0.017 DBMET02172 0.02 0.019 DBMET02175 0.026 0.009 DBMET02178 0.026 0.009 DBMET02183 0.025 0.01 DBMET02184 0.024 0.012 DBMET02173 0.026 0.009 DBMET02174 | DBMET02182 | |
| 0.098 | 0.093 | 0.114 | Acetylcholine muscarinic antagonist | 0.11 0.079 DBMET02180 0.114 0.074 DB12110 0.114 0.074 DBMET01878 0.103 0.087 DBMET02175 0.101 0.09 DBMET02176 | DBMET01878 | |
| 0.258 | 0.258 | 0.812 | Antiinflammatory | 0.607 0.052 DBMET02171 0.265 0.251 DBMET02180 0.544 0.07 DBMET02182 0.812 0.014 DBMET02169 0.72 0.027 DBMET02168 0.563 0.064 DBMET02175 0.579 0.059 DBMET02176 0.393 0.143 DBMET02177 0.796 0.016 DBMET02178 0.796 0.016 DBMET02183 0.511 0.083 DBMET02184 0.366 0.161 DBMET02173 | DBMET02169 | |
| 0.065 | 0.065 | 0.156 | Phospholipase D inhibitor | 0.156 0.003 DB12110 0.156 0.003 DBMET01878 | DBMET01878 | |
| 0.03 | 0.031 | 0.037 | Purinergic P2X7 antagonist | 0.037 0.024 DB12110 0.037 0.024 DBMET01878 | DBMET01878 | |
| 0.181 | 0.182 | 0.329 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.329 0.046 DB12110 0.329 0.046 DBMET01878 0.183 0.179 DBMET02172 | DBMET01878 | |
| 0.081 | 0.083 | 0.423 | DNA directed RNA polymerase inhibitor | 0.088 0.072 DBMET02182 0.423 0.005 DBMET02169 0.168 0.019 DBMET02168 0.12 0.037 DBMET02170 0.102 0.055 DBMET02184 | DBMET02169 | |
| 0.057 | 0.061 | 0.276 | Peroxisome proliferator-activated receptor gamma agonist | 0.06 0.057 DBMET02180 0.276 0.005 DBMET02182 0.143 0.014 DBMET02178 0.143 0.014 DBMET02183 0.182 0.008 DBMET02184 0.105 0.025 DBMET02173 0.09 0.034 DBMET02174 | DBMET02182 | |
| 0.025 | 0.032 | 0.033 | CXC chemokine 3 receptor antagonist | 0.033 0.02 DBMET02172 0.031 0.022 DBMET02174 | DBMET02172 | |
| 0.051 | 0.059 | 0.085 | Acetylcholine M5 receptor antagonist | 0.085 0.022 DB12110 0.085 0.022 DBMET01878 0.056 0.049 DBMET02175 | DBMET01878 | |
| 0.029 | 0.037 | 0.057 | p53 inhibitor | 0.057 0.01 DB12110 0.057 0.01 DBMET01878 0.032 0.031 DBMET01879 0.034 0.026 DBMET02168 | DBMET01878 | |
| 0.05 | 0.059 | 0.062 | Phosphodiesterase 1B inhibitor | 0.057 0.046 DBMET01879 0.062 0.04 DBMET02168 | DBMET02168 | |
| 0.009 | 0.018 | 0.062 | Angiotensin AT1B receptor antagonist | 0.062 0.002 DBMET02182 0.02 0.006 DBMET02168 0.018 0.007 DBMET02178 0.018 0.007 DBMET02183 0.046 0.003 DBMET02184 0.016 0.008 DBMET02173 0.024 0.005 DBMET02174 | DBMET02182 | |
| 0.028 | 0.038 | 0.097 | 5 Hydroxytryptamine 3B antagonist | 0.097 0.005 DB12110 0.097 0.005 DBMET01878 | DBMET01878 | |
| 0.048 | 0.059 | 0.153 | 5 Hydroxytryptamine 7 agonist | 0.153 0.004 DB12110 0.153 0.004 DBMET01878 | DBMET01878 | |
| 0.042 | 0.053 | 0.046 | Phosphodiesterase 6C inhibitor | 0.046 0.034 DBMET02182 0.044 0.041 DBMET02168 | DBMET02182 | |
| 0.138 | 0.15 | 0.417 | Hypolipemic | 0.146 0.141 DBMET02180 0.417 0.022 DBMET02182 0.336 0.039 DBMET02178 0.336 0.039 DBMET02183 0.392 0.027 DBMET02184 0.245 0.07 DBMET02173 | DBMET02182 | |
| 0.027 | 0.04 | 0.082 | NMDA receptor subunit 3A antagonist | 0.047 0.021 DBMET02182 0.082 0.011 DB12110 0.082 0.011 DBMET01878 | DBMET01878 | |
| 0.075 | 0.089 | 0.108 | Phosphodiesterase I inhibitor | 0.086 0.066 DBMET02182 0.09 0.059 DBMET01879 0.108 0.036 DBMET02168 0.081 0.074 DBMET02184 | DBMET02168 | |
| 0.029 | 0.045 | 0.057 | Somatostatin 4 agonist | 0.057 0.013 DB12110 0.057 0.013 DBMET01878 | DBMET01878 | |
| 0.02 | 0.036 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 DB12110 0.023 0.021 DBMET01878 | DBMET01878 | |
| 0.068 | 0.084 | 0.209 | NMDA receptor antagonist | 0.209 0.013 DB12110 0.209 0.013 DBMET01878 | DBMET01878 | |
| 0.116 | 0.134 | 0.185 | Neuropeptide Y1 antagonist | 0.185 0.026 DB12110 0.185 0.026 DBMET01878 | DBMET01878 | |
| 0.043 | 0.062 | 0.173 | 5 Hydroxytryptamine 6 antagonist | 0.173 0.005 DB12110 0.173 0.005 DBMET01878 | DBMET01878 | |
| 0.026 | 0.047 | 0.054 | Estrogen-related receptor beta antagonist | 0.032 0.023 DBMET02180 0.054 0.005 DB12110 0.054 0.005 DBMET01878 | DBMET01878 | |
| 0.088 | 0.11 | 0.124 | Acetylcholine antagonist | 0.124 0.067 DB12110 0.124 0.067 DBMET01878 | DBMET01878 | |
| 0.041 | 0.063 | 0.238 | 5 Hydroxytryptamine 3 antagonist | 0.238 0.005 DB12110 0.238 0.005 DBMET01878 | DBMET01878 | |
| 0.089 | 0.113 | 0.127 | Cholinergic antagonist | 0.127 0.068 DB12110 0.127 0.068 DBMET01878 | DBMET01878 | |
| 0.073 | 0.1 | 0.235 | Creatine kinase inhibitor | 0.106 0.053 DBMET02180 0.159 0.02 DBMET02182 0.116 0.044 DB12110 0.116 0.044 DBMET01878 0.235 0.006 DBMET01879 0.133 0.032 DBMET02169 0.09 0.072 DBMET02168 0.09 0.071 DBMET02170 0.098 0.061 DBMET02175 0.09 0.072 DBMET02176 0.133 0.032 DBMET02178 0.133 0.032 DBMET02183 0.099 0.061 DBMET02174 | DBMET01879 | |
| 0.074 | 0.106 | 0.299 | Lanosterol 14 alpha demethylase inhibitor | 0.114 0.037 DBMET02171 0.171 0.007 DB12110 0.171 0.007 DBMET01878 0.299 0.003 DBMET01879 0.091 0.071 DBMET02169 0.093 0.067 DBMET02178 0.093 0.067 DBMET02183 0.091 0.07 DBMET02174 | DBMET01879 | |
| 0.024 | 0.059 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.025 DB12110 0.031 0.025 DBMET01878 | DBMET01878 | |
| 0.042 | 0.078 | 0.1 | Calcium channel T-type blocker | 0.1 0.016 DB12110 0.1 0.016 DBMET01878 | DBMET01878 | |
| 0.042 | 0.078 | 0.05 | Alpha 1L adrenoreceptor antagonist | 0.05 0.041 DBMET02175 | DBMET02175 | |
| 0.047 | 0.083 | 0.129 | 5 Hydroxytryptamine 5A antagonist | 0.129 0.01 DB12110 0.129 0.01 DBMET01878 | DBMET01878 | |
| 0.216 | 0.253 | 0.595 | Cyclophilin D inhibitor | 0.308 0.156 DBMET02171 0.573 0.032 DBMET02182 0.332 0.136 DBMET01879 0.367 0.111 DBMET02169 0.237 0.228 DBMET02168 0.281 0.18 DBMET02175 0.29 0.172 DBMET02176 0.595 0.028 DBMET02178 0.595 0.028 DBMET02183 0.388 0.098 DBMET02184 | DBMET02183 | |
| 0.015 | 0.054 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 DB12110 0.038 0.016 DBMET01878 0.028 0.023 DBMET02168 | DBMET01878 | |
| 0.03 | 0.071 | 0.058 | Purinergic P2X antagonist | 0.058 0.025 DB12110 0.058 0.025 DBMET01878 | DBMET01878 | |
| 0.012 | 0.056 | 0.03 | CC chemokine 1 receptor antagonist | 0.03 0.013 DB12110 0.03 0.013 DBMET01878 | DBMET01878 | |
| 0.022 | 0.069 | 0.076 | Vascular adhesion protein 1 inhibitor | 0.076 0.005 DB12110 0.076 0.005 DBMET01878 | DBMET01878 | |
| 0.041 | 0.09 | 0.126 | 5 Hydroxytryptamine 5 antagonist | 0.126 0.011 DB12110 0.126 0.011 DBMET01878 | DBMET01878 | |
| 0.005 | 0.054 | 0.096 | Peroxisome proliferator-activated receptor alpha antagonist | 0.096 0.005 DBMET02182 0.025 0.013 DBMET02178 0.025 0.013 DBMET02183 0.024 0.014 DBMET02184 | DBMET02182 | |
| 0.047 | 0.099 | 0.117 | Benzodiazepine agonist | 0.117 0.017 DB12110 0.117 0.017 DBMET01878 | DBMET01878 | |
| 0.095 | 0.149 | 0.208 | Diuretic | 0.208 0.041 DBMET02182 0.135 0.09 DB12110 0.135 0.09 DBMET01878 0.115 0.111 DBMET01879 0.204 0.043 DBMET02178 0.204 0.043 DBMET02183 0.12 0.105 DBMET02184 0.185 0.05 DBMET02174 | DBMET02182 | |
| 0.086 | 0.141 | 0.259 | Toll-Like receptor 9 antagonist | 0.259 0.019 DB12110 0.259 0.019 DBMET01878 | DBMET01878 | |
| 0.015 | 0.07 | 0.108 | Potassium channel small-conductance Ca-activated activator | 0.108 0.004 DB12110 0.108 0.004 DBMET01878 | DBMET01878 | |
| 0.022 | 0.079 | 0.057 | Acetylcholine M1 receptor agonist | 0.057 0.023 DB12110 0.057 0.023 DBMET01878 | DBMET01878 | |
| 0.028 | 0.087 | 0.054 | Adenosine A1 receptor antagonist | 0.054 0.044 DBMET02168 | DBMET02168 | |
| 0.016 | 0.076 | 0.04 | Acid ceramidase inhibitor | 0.04 0.004 DB12110 0.04 0.004 DBMET01878 | DBMET01878 | |
| 0.026 | 0.09 | 0.075 | Nerve growth factor antagonist | 0.075 0.004 DB12110 0.075 0.004 DBMET01878 | DBMET01878 | |
| 0.034 | 0.099 | 0.087 | CC chemokine receptor 2B antagonist | 0.087 0.007 DB12110 0.087 0.007 DBMET01878 | DBMET01878 | |
| 0.065 | 0.132 | 0.081 | Ca(v)3.1 blocker | 0.081 0.057 DB12110 0.081 0.057 DBMET01878 | DBMET01878 | |
| 0.064 | 0.132 | 0.17 | Bromodomain-containing protein 2 inhibitor | 0.17 0.005 DB12110 0.17 0.005 DBMET01878 | DBMET01878 | |
| 0.028 | 0.097 | 0.07 | Acetylcholine muscarinic agonist | 0.07 0.027 DB12110 0.07 0.027 DBMET01878 | DBMET01878 | |
| 0.09 | 0.161 | 0.195 | Acetylcholine M1 receptor antagonist | 0.195 0.045 DB12110 0.195 0.045 DBMET01878 | DBMET01878 | |
| 0.033 | 0.106 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.027 DB12110 0.056 0.027 DBMET01878 | DBMET01878 | |
| 0.033 | 0.107 | 0.133 | Heme oxygenase inhibitor | 0.05 0.013 DB12110 0.05 0.013 DBMET01878 0.133 0.002 DBMET01879 | DBMET01879 | |
| 0.057 | 0.131 | 0.181 | Sphingosine 1-phosphate receptor antagonist | 0.149 0.006 DBMET02182 0.181 0.005 DBMET01879 0.088 0.032 DBMET02178 0.088 0.032 DBMET02183 0.098 0.023 DBMET02184 | DBMET01879 | |
| 0.074 | 0.15 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.227 0.027 DB12110 0.227 0.027 DBMET01878 | DBMET01878 | |
| 0.027 | 0.104 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 DB12110 0.071 0.009 DBMET01878 0.055 0.021 DBMET01879 | DBMET01878 | |
| 0.008 | 0.085 | 0.026 | Urotensin II antagonist | 0.026 0.012 DB12110 0.026 0.012 DBMET01878 | DBMET01878 | |
| 0.031 | 0.111 | 0.065 | Purinergic P2 antagonist | 0.065 0.043 DB12110 0.065 0.043 DBMET01878 | DBMET01878 | |
| 0.007 | 0.088 | 0.032 | Dopamine autoreceptor agonist | 0.032 0.012 DB12110 0.032 0.012 DBMET01878 | DBMET01878 | |
| 0.061 | 0.143 | 0.14 | Phosphodiesterase 7B inhibitor | 0.14 0.025 DB12110 0.14 0.025 DBMET01878 | DBMET01878 | |
| 0.007 | 0.089 | 0.051 | Cholecystokinin B antagonist | 0.04 0.014 DBMET02182 0.029 0.022 DBMET02178 0.029 0.022 DBMET02183 0.051 0.01 DBMET02174 | DBMET02174 | |
| 0.032 | 0.114 | 0.055 | Cytokine production stimulant | 0.046 0.041 DBMET02182 0.055 0.018 DBMET02184 | DBMET02184 | |
| 0.048 | 0.131 | 0.069 | Adenosine A3 receptor antagonist | 0.069 0.061 DBMET01879 | DBMET01879 | |
| 0.024 | 0.108 | 0.066 | Dopamine transporter inhibitor | 0.066 0.022 DB12110 0.066 0.022 DBMET01878 | DBMET01878 | |
| 0.062 | 0.147 | 0.18 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET02180 0.18 0.03 DBMET02182 0.136 0.047 DB12110 0.136 0.047 DBMET01878 0.122 0.056 DBMET01879 0.109 0.068 DBMET02169 0.104 0.072 DBMET02170 0.102 0.075 DBMET02176 0.142 0.044 DBMET02178 0.142 0.044 DBMET02183 0.153 0.039 DBMET02184 0.171 0.033 DBMET02173 0.124 0.055 DBMET02174 | DBMET02182 | |
| 0.01 | 0.096 | 0.066 | Cholecystokinin antagonist | 0.056 0.021 DBMET02182 0.035 0.032 DBMET02178 0.035 0.032 DBMET02183 0.066 0.016 DBMET02174 | DBMET02174 | |
| 0.036 | 0.124 | 0.197 | Sphingosine 1-phosphate receptor 1 antagonist | 0.122 0.005 DBMET02182 0.197 0.004 DBMET01879 0.062 0.026 DBMET02178 0.062 0.026 DBMET02183 0.068 0.02 DBMET02184 | DBMET01879 | |
| 0.04 | 0.132 | 0.109 | Bcl2 antagonist | 0.109 0.014 DB12110 0.109 0.014 DBMET01878 | DBMET01878 | |
| 0.014 | 0.108 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 DB12110 0.03 0.017 DBMET01878 | DBMET01878 | |
| 0.021 | 0.116 | 0.063 | Bromodomain-containing protein 3 inhibitor | 0.063 0.017 DB12110 0.063 0.017 DBMET01878 | DBMET01878 | |
| 0.031 | 0.126 | 0.06 | Parathyroid hormone antagonist | 0.06 0.011 DB12110 0.06 0.011 DBMET01878 | DBMET01878 | |
| 0.037 | 0.136 | 0.091 | Heat shock protein 90 beta antagonist | 0.078 0.022 DBMET02180 0.091 0.014 DB12110 0.091 0.014 DBMET01878 0.056 0.046 DBMET02168 | DBMET01878 | |
| 0.033 | 0.137 | 0.066 | Alpha 1b adrenoreceptor agonist | 0.065 0.015 DB12110 0.065 0.015 DBMET01878 0.066 0.014 DBMET01879 | DBMET01879 | |
| 0.044 | 0.149 | 0.17 | Histamine N-methyltransferase inhibitor | 0.17 0.009 DB12110 0.17 0.009 DBMET01878 | DBMET01878 | |
| 0.015 | 0.12 | 0.063 | Cyclin D3 inhibitor | 0.063 0.016 DB12110 0.063 0.016 DBMET01878 | DBMET01878 | |
| 0.054 | 0.16 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 DB12110 0.082 0.074 DBMET01878 | DBMET01878 | |
| 0.014 | 0.125 | 0.132 | Peroxisome proliferator-activated receptor alpha agonist | 0.132 0.008 DBMET02182 0.056 0.028 DBMET02178 0.056 0.028 DBMET02183 0.088 0.015 DBMET02184 | DBMET02182 | |
| 0.092 | 0.204 | 0.223 | GABA C receptor rho-2 antagonist | 0.152 0.071 DBMET02182 0.223 0.019 DB12110 0.223 0.019 DBMET01878 0.205 0.026 DBMET01879 0.179 0.043 DBMET02168 0.138 0.091 DBMET02170 0.17 0.051 DBMET02184 0.129 0.107 DBMET02173 | DBMET01878 | |
| 0.021 | 0.134 | 0.107 | Cannabinoid CB1 receptor agonist | 0.107 0.017 DBMET02168 0.068 0.037 DBMET02170 | DBMET02168 | |
| 0.025 | 0.139 | 0.103 | Histamine agonist | 0.103 0.009 DB12110 0.103 0.009 DBMET01878 | DBMET01878 | |
| 0.015 | 0.13 | 0.044 | Estrogen-related receptor gamma antagonist | 0.044 0.004 DB12110 0.044 0.004 DBMET01878 | DBMET01878 | |
| 0.023 | 0.143 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DB12110 0.076 0.023 DBMET01878 0.073 0.024 DBMET01879 | DBMET01878 | |
| 0.101 | 0.221 | 0.286 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 DB12110 0.286 0.015 DBMET01878 0.135 0.13 DBMET02168 | DBMET01878 | |
| 0.043 | 0.162 | 0.152 | Acetylcholine agonist | 0.152 0.025 DB12110 0.152 0.025 DBMET01878 | DBMET01878 | |
| 0.027 | 0.148 | 0.126 | HIV-1 reverse transcriptase inhibitor | 0.126 0.02 DBMET02169 0.062 0.057 DBMET02168 | DBMET02169 | |
| 0.007 | 0.127 | 0.02 | Cyclin D2 inhibitor | 0.02 0.004 DB12110 0.02 0.004 DBMET01878 | DBMET01878 | |
| 0.042 | 0.163 | 0.137 | Adrenaline agonist | 0.074 0.065 DBMET02171 0.105 0.034 DB12110 0.105 0.034 DBMET01878 0.137 0.018 DBMET02175 0.102 0.036 DBMET02176 | DBMET02175 | |
| 0.121 | 0.244 | 0.488 | Superoxide dismutase inhibitor | 0.488 0.014 DB12110 0.488 0.014 DBMET01878 0.213 0.104 DBMET01879 0.242 0.08 DBMET02168 0.24 0.081 DBMET02170 | DBMET01878 | |
| 0.032 | 0.156 | 0.191 | Cyclin B3 inhibitor | 0.191 0.007 DB12110 0.191 0.007 DBMET01878 | DBMET01878 | |
| 0.063 | 0.188 | 0.159 | Phosphodiesterase inhibitor | 0.159 0.053 DBMET02179 0.109 0.094 DBMET02168 0.122 0.081 DBMET02184 | DBMET02179 | |
| 0.009 | 0.136 | 0.065 | Kainate receptor 2 antagonist | 0.032 0.028 DBMET02182 0.065 0.01 DB12110 0.065 0.01 DBMET01878 0.04 0.022 DBMET01879 | DBMET01878 | |
| 0.193 | 0.32 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.48 0.039 DB12110 0.48 0.039 DBMET01878 0.402 0.077 DBMET01879 0.319 0.145 DBMET02169 0.379 0.092 DBMET02168 0.461 0.047 DBMET02170 0.26 0.215 DBMET02172 0.292 0.175 DBMET02174 | DBMET01878 | |
| 0.032 | 0.163 | 0.224 | 5 Hydroxytryptamine 3 agonist | 0.224 0.003 DB12110 0.224 0.003 DBMET01878 | DBMET01878 | |
| 0.053 | 0.185 | 0.278 | GABA receptor agonist | 0.144 0.039 DB12110 0.144 0.039 DBMET01878 0.278 0.008 DBMET01879 | DBMET01879 | |
| 0.026 | 0.159 | 0.13 | Histamine H4 receptor antagonist | 0.13 0.004 DB12110 0.13 0.004 DBMET01878 | DBMET01878 | |
| 0.027 | 0.16 | 0.101 | Cyclin D1 inhibitor | 0.101 0.008 DB12110 0.101 0.008 DBMET01878 | DBMET01878 | |
| 0.054 | 0.187 | 0.097 | Polo-like kinase-1 inhibitor | 0.093 0.056 DBMET02179 0.097 0.049 DB12110 0.097 0.049 DBMET01878 0.086 0.07 DBMET02177 | DBMET01878 | |
| 0.014 | 0.148 | 0.044 | Oleamide hydrolase inhibitor | 0.044 0.033 DBMET01879 | DBMET01879 | |
| 0.021 | 0.156 | 0.078 | GABA receptor antagonist | 0.076 0.023 DB12110 0.076 0.023 DBMET01878 0.078 0.022 DBMET01879 | DBMET01879 | |
| 0.054 | 0.189 | 0.207 | Protein kinase C zeta inhibitor | 0.207 0.01 DB12110 0.207 0.01 DBMET01878 | DBMET01878 | |
| 0.049 | 0.186 | 0.513 | Ferrochelatase inhibitor | 0.098 0.073 DBMET02171 0.425 0.003 DBMET02182 0.169 0.031 DB12110 0.169 0.031 DBMET01878 0.403 0.004 DBMET01879 0.408 0.004 DBMET02169 0.218 0.019 DBMET02168 0.153 0.036 DBMET02170 0.513 0.002 DBMET02178 0.513 0.002 DBMET02183 0.154 0.036 DBMET02184 0.103 0.068 DBMET02173 0.251 0.013 DBMET02174 | DBMET02183 | |
| 0.018 | 0.155 | 0.235 | 5 Hydroxytryptamine 2 agonist | 0.235 0.004 DB12110 0.235 0.004 DBMET01878 | DBMET01878 | |
| 0.112 | 0.253 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 DBMET02182 0.149 0.045 DB12110 0.149 0.045 DBMET01878 0.16 0.023 DBMET01879 0.137 0.085 DBMET02169 0.133 0.102 DBMET02168 0.145 0.057 DBMET02170 0.135 0.096 DBMET02178 0.135 0.096 DBMET02183 0.137 0.083 DBMET02174 | DBMET01879 | |
| 0.013 | 0.155 | 0.033 | Thymidine phosphorylase inhibitor | 0.029 0.013 DB12110 0.029 0.013 DBMET01878 0.031 0.01 DBMET01879 0.033 0.009 DBMET02168 0.026 0.019 DBMET02170 | DBMET02168 | |
| 0.022 | 0.165 | 0.071 | Phosphodiesterase VII inhibitor | 0.071 0.034 DB12110 0.071 0.034 DBMET01878 | DBMET01878 | |
| 0.011 | 0.154 | 0.07 | Melanin-concentrating hormone receptor 1 antagonist | 0.07 0.024 DB12110 0.07 0.024 DBMET01878 | DBMET01878 | |
| 0.036 | 0.18 | 0.08 | Interferon inducer | 0.069 0.036 DBMET02182 0.064 0.045 DBMET02169 0.067 0.04 DBMET02168 0.08 0.024 DBMET02184 | DBMET02184 | |
| 0.034 | 0.177 | 0.101 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.101 0.01 DB12110 0.101 0.01 DBMET01878 0.069 0.029 DBMET01879 | DBMET01878 | |
| 0.019 | 0.163 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 DB12110 0.04 0.028 DBMET01878 | DBMET01878 | |
| 0.02 | 0.165 | 0.061 | Histamine H1 receptor agonist | 0.061 0.008 DB12110 0.061 0.008 DBMET01878 0.044 0.029 DBMET02168 | DBMET01878 | |
| 0.022 | 0.168 | 0.252 | Carbamoyl phosphate synthetase inhibitor | 0.193 0.008 DBMET02182 0.252 0.005 DBMET01879 0.136 0.013 DBMET02169 0.082 0.027 DBMET02168 0.077 0.03 DBMET02170 0.186 0.008 DBMET02178 0.186 0.008 DBMET02183 0.07 0.035 DBMET02184 0.067 0.036 DBMET02173 0.122 0.015 DBMET02174 | DBMET01879 | |
| 0.054 | 0.202 | 0.171 | Electrolyte absorption antagonist | 0.113 0.043 DBMET02182 0.171 0.013 DB12110 0.171 0.013 DBMET01878 0.125 0.032 DBMET01879 0.088 0.078 DBMET02169 0.114 0.041 DBMET02168 0.097 0.062 DBMET02170 | DBMET01878 | |
| 0.081 | 0.231 | 0.15 | Polo-like kinase-3 inhibitor | 0.15 0.084 DB12110 0.15 0.084 DBMET01878 | DBMET01878 | |
| 0.05 | 0.202 | 0.167 | NADH dehydrogenase inhibitor | 0.132 0.023 DBMET02182 0.141 0.02 DB12110 0.141 0.02 DBMET01878 0.167 0.014 DBMET01879 0.156 0.016 DBMET02169 0.104 0.04 DBMET02168 0.106 0.038 DBMET02170 0.126 0.025 DBMET02178 0.126 0.025 DBMET02183 0.08 0.074 DBMET02184 0.087 0.062 DBMET02174 | DBMET01879 | |
| 0.037 | 0.19 | 0.1 | Interferon agonist | 0.093 0.035 DBMET02182 0.077 0.058 DBMET02169 0.078 0.056 DBMET02168 0.1 0.029 DBMET02184 0.072 0.067 DBMET02173 | DBMET02184 | |
| 0.059 | 0.213 | 0.127 | Alpha 2d adrenoreceptor antagonist | 0.1 0.049 DB12110 0.1 0.049 DBMET01878 0.086 0.083 DBMET02169 0.127 0.019 DBMET02168 0.091 0.069 DBMET02170 | DBMET02168 | |
| 0.137 | 0.291 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.3 0.005 DB12110 0.3 0.005 DBMET01878 0.175 0.121 DBMET02168 0.167 0.147 DBMET02170 | DBMET01878 | |
| 0.059 | 0.214 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 DB12110 0.087 0.044 DBMET01878 | DBMET01878 | |
| 0.012 | 0.167 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.028 DB12110 0.032 0.028 DBMET01878 | DBMET01878 | |
| 0.021 | 0.177 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.032 DB12110 0.049 0.032 DBMET01878 | DBMET01878 | |
| 0.005 | 0.161 | 0.052 | Histamine H4 receptor agonist | 0.052 0.004 DB12110 0.052 0.004 DBMET01878 | DBMET01878 | |
| 0.008 | 0.165 | 0.036 | Prostaglandin EP4 antagonist | 0.036 0.012 DBMET02182 | DBMET02182 | |
| 0.048 | 0.205 | 0.187 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.187 0.018 DBMET02182 0.153 0.026 DB12110 0.153 0.026 DBMET01878 0.145 0.028 DBMET01879 0.099 0.055 DBMET02169 0.094 0.061 DBMET02168 0.101 0.053 DBMET02170 0.142 0.029 DBMET02178 0.142 0.029 DBMET02183 0.118 0.04 DBMET02174 | DBMET02182 | |
| 0.106 | 0.263 | 0.346 | 5 Hydroxytryptamine 1E antagonist | 0.346 0.011 DB12110 0.346 0.011 DBMET01878 | DBMET01878 | |
| 0.003 | 0.161 | 0.019 | Integrin beta2 antagonist | 0.019 0.005 DB12110 0.019 0.005 DBMET01878 | DBMET01878 | |
| 0.004 | 0.165 | 0.043 | AMPA 1 receptor antagonist | 0.031 0.019 DB12110 0.031 0.019 DBMET01878 0.043 0.013 DBMET01879 | DBMET01879 | |
| 0.025 | 0.189 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 DB12110 0.073 0.016 DBMET01878 | DBMET01878 | |
| 0.024 | 0.199 | 0.175 | Nicotinic alpha4beta2 receptor antagonist | 0.175 0.005 DB12110 0.175 0.005 DBMET01878 | DBMET01878 | |
| 0.024 | 0.201 | 0.105 | Toll-Like receptor 7 antagonist | 0.105 0.018 DB12110 0.105 0.018 DBMET01878 | DBMET01878 | |
| 0.031 | 0.208 | 0.063 | Ca(v)3.2 blocker | 0.063 0.033 DB12110 0.063 0.033 DBMET01878 | DBMET01878 | |
| 0.043 | 0.221 | 0.111 | Insulin receptor antagonist | 0.111 0.05 DB12110 0.111 0.05 DBMET01878 | DBMET01878 | |
| 0.056 | 0.236 | 0.23 | Activin receptor-like kinase 2 inhibitor | 0.23 0.026 DB12110 0.23 0.026 DBMET01878 | DBMET01878 | |
| 0.009 | 0.188 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 DB12110 0.039 0.025 DBMET01878 | DBMET01878 | |
| 0.003 | 0.191 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 DB12110 0.022 0.014 DBMET01878 | DBMET01878 | |
| 0.058 | 0.247 | 0.184 | Nav1.2 sodium channel blocker | 0.184 0.04 DB12110 0.184 0.04 DBMET01878 | DBMET01878 | |
| 0.001 | 0.194 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DBMET01879 | DBMET01879 | |
| 0.147 | 0.341 | 0.202 | MAP kinase kinase 3 inhibitor | 0.202 0.118 DBMET02169 | DBMET02169 | |
| 0.015 | 0.211 | 0.057 | AMPA 4 receptor antagonist | 0.04 0.026 DB12110 0.04 0.026 DBMET01878 0.057 0.011 DBMET01879 | DBMET01879 | |
| 0.006 | 0.202 | 0.035 | Cyclin E2 inhibitor | 0.035 0.015 DB12110 0.035 0.015 DBMET01878 | DBMET01878 | |
| 0.021 | 0.217 | 0.092 | Protein kinase C beta inhibitor | 0.092 0.018 DB12110 0.092 0.018 DBMET01878 0.08 0.03 DBMET01879 | DBMET01878 | |
| 0.018 | 0.214 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.027 DB12110 0.049 0.027 DBMET01878 0.044 0.035 DBMET02168 | DBMET01878 | |
| 0.056 | 0.252 | 0.141 | Antibacterial (Helicobacter pylori) | 0.141 0.055 DB12110 0.141 0.055 DBMET01878 | DBMET01878 | |
| 0.023 | 0.22 | 0.069 | CC chemokine receptor antagonist | 0.069 0.064 DB12110 0.069 0.064 DBMET01878 | DBMET01878 | |
| 0.036 | 0.233 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.094 0.019 DBMET02182 0.075 0.041 DBMET02178 0.075 0.041 DBMET02183 0.076 0.041 DBMET02184 | DBMET02182 | |
| 0.085 | 0.284 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.145 0.069 DBMET02182 0.138 0.083 DB12110 0.138 0.083 DBMET01878 0.182 0.022 DBMET01879 | DBMET01879 | |
| 0.023 | 0.223 | 0.09 | Alpha 1L adrenoreceptor agonist | 0.09 0.003 DB12110 0.09 0.003 DBMET01878 | DBMET01878 | |
| 0.016 | 0.217 | 0.036 | Vanilloid 4 antagonist | 0.036 0.016 DB12110 0.036 0.016 DBMET01878 | DBMET01878 | |
| 0.056 | 0.259 | 0.234 | Toll-Like receptor antagonist | 0.234 0.02 DB12110 0.234 0.02 DBMET01878 | DBMET01878 | |
| 0.006 | 0.208 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.01 DB12110 0.018 0.01 DBMET01878 | DBMET01878 | |
| 0.006 | 0.21 | 0.07 | Methionyl aminopeptidase 1 inhibitor | 0.07 0.004 DB12110 0.07 0.004 DBMET01878 | DBMET01878 | |
| 0.014 | 0.219 | 0.063 | Cannabinoid receptor agonist | 0.063 0.046 DBMET02168 | DBMET02168 | |
| 0.019 | 0.224 | 0.123 | Neuronal nicotinic receptor antagonist | 0.123 0.017 DB12110 0.123 0.017 DBMET01878 | DBMET01878 | |
| 0.016 | 0.225 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.016 DB12110 0.05 0.016 DBMET01878 | DBMET01878 | |
| 0.037 | 0.247 | 0.2 | Glutamate receptor antagonist | 0.2 0.025 DB12110 0.2 0.025 DBMET01878 | DBMET01878 | |
| 0.008 | 0.217 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 DBMET02168 | DBMET02168 | |
| 0.023 | 0.233 | 0.136 | Acetylcholine nicotinic antagonist | 0.136 0.025 DB12110 0.136 0.025 DBMET01878 | DBMET01878 | |
| 0.027 | 0.24 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 DB12110 0.06 0.032 DBMET01878 0.058 0.035 DBMET02168 | DBMET01878 | |
| 0.065 | 0.279 | 0.171 | Potassium channel blocker | 0.171 0.115 DB12110 0.171 0.115 DBMET01878 | DBMET01878 | |
| 0.041 | 0.255 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 DB12110 0.071 0.027 DBMET01878 | DBMET01878 | |
| 0.043 | 0.257 | 0.138 | Nav1.3 sodium channel blocker | 0.138 0.056 DB12110 0.138 0.056 DBMET01878 | DBMET01878 | |
| 0.009 | 0.226 | 0.048 | 5 Hydroxytryptamine 6 agonist | 0.048 0.005 DB12110 0.048 0.005 DBMET01878 | DBMET01878 | |
| 0.013 | 0.232 | 0.027 | Complement factor 1r inhibitor | 0.027 0.015 DB12110 0.027 0.015 DBMET01878 | DBMET01878 | |
| 0.007 | 0.227 | 0.322 | 5 Hydroxytryptamine 2C agonist | 0.322 0.003 DB12110 0.322 0.003 DBMET01878 | DBMET01878 | |
| 0.014 | 0.234 | 0.081 | Phosphodiesterase 4C inhibitor | 0.068 0.028 DBMET02168 0.081 0.02 DBMET02170 | DBMET02170 | |
| 0.082 | 0.303 | 0.189 | Neurotrophic factor enhancer | 0.189 0.088 DB12110 0.189 0.088 DBMET01878 | DBMET01878 | |
| 0.015 | 0.238 | 0.205 | 5 Hydroxytryptamine 2B agonist | 0.205 0.002 DB12110 0.205 0.002 DBMET01878 | DBMET01878 | |
| 0.098 | 0.322 | 0.307 | MAP-kinase-activated kinase 5 inhibitor | 0.307 0.026 DB12110 0.307 0.026 DBMET01878 | DBMET01878 | |
| 0.028 | 0.252 | 0.113 | Chemokine receptor antagonist | 0.113 0.053 DB12110 0.113 0.053 DBMET01878 | DBMET01878 | |
| 0.129 | 0.354 | 0.341 | Analgesic | 0.279 0.159 DB12110 0.279 0.159 DBMET01878 0.341 0.113 DBMET02168 | DBMET02168 | |
| 0.071 | 0.299 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 DB12110 0.126 0.047 DBMET01878 | DBMET01878 | |
| 0.035 | 0.264 | 0.09 | EphA2 antagonist | 0.09 0.087 DB12110 0.09 0.087 DBMET01878 | DBMET01878 | |
| 0.014 | 0.243 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 DB12110 0.047 0.007 DBMET01878 0.041 0.014 DBMET01879 | DBMET01878 | |
| 0.079 | 0.309 | 0.279 | Succinate dehydrogenase inhibitor | 0.247 0.023 DBMET02182 0.197 0.051 DB12110 0.197 0.051 DBMET01878 0.279 0.014 DBMET01879 0.195 0.053 DBMET02169 0.168 0.083 DBMET02168 0.185 0.062 DBMET02170 0.224 0.033 DBMET02178 0.224 0.033 DBMET02183 0.148 0.116 DBMET02184 0.166 0.086 DBMET02173 0.212 0.04 DBMET02174 | DBMET01879 | |
| 0.034 | 0.265 | 0.073 | ErbB-3 antagonist | 0.073 0.071 DBMET01879 | DBMET01879 | |
| 0.008 | 0.239 | 0.459 | Substance P antagonist | 0.038 0.029 DBMET02169 0.459 0.003 DBMET02168 0.401 0.003 DBMET02170 | DBMET02168 | |
| 0.152 | 0.383 | 0.323 | MAP kinase kinase 6 inhibitor | 0.323 0.114 DB12110 0.323 0.114 DBMET01878 | DBMET01878 | |
| 0.001 | 0.233 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 DB12110 0.014 0.006 DBMET01878 | DBMET01878 | |
| 0.013 | 0.25 | 0.109 | Acetylcholine M5 receptor agonist | 0.109 0.015 DB12110 0.109 0.015 DBMET01878 | DBMET01878 | |
| 0.087 | 0.324 | 0.18 | Thyroid hormone beta antagonist | 0.18 0.174 DB12110 0.18 0.174 DBMET01878 | DBMET01878 | |
| 0.112 | 0.351 | 0.256 | ErbB-1 antagonist | 0.256 0.049 DB12110 0.256 0.049 DBMET01878 | DBMET01878 | |
| 0.007 | 0.25 | 0.044 | LFA antagonist | 0.044 0.007 DB12110 0.044 0.007 DBMET01878 | DBMET01878 | |
| 0.04 | 0.284 | 0.085 | Thioredoxin inhibitor | 0.085 0.072 DBMET01879 0.084 0.073 DBMET02184 0.085 0.071 DBMET02173 | DBMET02173 | |
| 0.006 | 0.252 | 0.05 | AMPA receptor antagonist | 0.05 0.031 DB12110 0.05 0.031 DBMET01878 0.045 0.036 DBMET01879 | DBMET01878 | |
| 0.008 | 0.254 | 0.046 | Nicotinic acid receptor agonist | 0.046 0.016 DBMET02168 | DBMET02168 | |
| 0.015 | 0.263 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 DB12110 0.056 0.01 DBMET01878 | DBMET01878 | |
| 0.088 | 0.336 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.161 0.083 DB12110 0.161 0.083 DBMET01878 | DBMET01878 | |
| 0.03 | 0.278 | 0.115 | Urease inhibitor | 0.115 0.05 DB12110 0.115 0.05 DBMET01878 0.086 0.082 DBMET02169 | DBMET01878 | |
| 0.032 | 0.281 | 0.089 | Sphingomyelinase inhibitor | 0.089 0.074 DB12110 0.089 0.074 DBMET01878 | DBMET01878 | |
| 0.06 | 0.309 | 0.171 | Transcription factor STAT6 inhibitor | 0.171 0.013 DB12110 0.171 0.013 DBMET01878 | DBMET01878 | |
| 0.004 | 0.254 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 DB12110 0.029 0.013 DBMET01878 | DBMET01878 | |
| 0.013 | 0.263 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DBMET02168 | DBMET02168 | |
| 0.018 | 0.269 | 0.285 | Phosphodiesterase III inhibitor | 0.285 0.004 DBMET02168 0.176 0.008 DBMET02170 | DBMET02168 | |
| 0.005 | 0.257 | 0.055 | Kainate receptor antagonist | 0.055 0.019 DB12110 0.055 0.019 DBMET01878 | DBMET01878 | |
| 0.009 | 0.262 | 0.055 | Glutamate (mGluR5) agonist | 0.055 0.021 DB12110 0.055 0.021 DBMET01878 | DBMET01878 | |
| 0.012 | 0.266 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 DB12110 0.04 0.017 DBMET01878 | DBMET01878 | |
| 0.091 | 0.346 | 0.242 | Catenin beta inhibitor | 0.175 0.058 DBMET02182 0.175 0.059 DB12110 0.175 0.059 DBMET01878 0.242 0.013 DBMET01879 0.146 0.117 DBMET02184 | DBMET01879 | |
| 0.018 | 0.275 | 0.065 | Potassium channel small-conductance Ca-activated blocker | 0.065 0.015 DB12110 0.065 0.015 DBMET01878 | DBMET01878 | |
| 0.004 | 0.265 | 0.077 | Kynurenine 3 monooxygenase inhibitor | 0.077 0.004 DBMET01879 | DBMET01879 | |
| 0.066 | 0.328 | 0.147 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.147 0.132 DB12110 0.147 0.132 DBMET01878 | DBMET01878 | |
| 0.006 | 0.269 | 0.096 | Fumarate hydratase inhibitor | 0.083 0.007 DBMET02182 0.096 0.005 DBMET01879 0.044 0.016 DBMET02169 0.071 0.008 DBMET02178 0.071 0.008 DBMET02183 0.044 0.016 DBMET02184 0.039 0.019 DBMET02173 0.042 0.017 DBMET02174 | DBMET01879 | |
| 0.017 | 0.28 | 0.083 | CXC chemokine receptor antagonist | 0.083 0.034 DB12110 0.083 0.034 DBMET01878 | DBMET01878 | |
| 0.013 | 0.278 | 0.065 | CC chemokine 2 receptor antagonist | 0.065 0.028 DB12110 0.065 0.028 DBMET01878 | DBMET01878 | |
| 0.048 | 0.315 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 DB12110 0.139 0.024 DBMET01878 | DBMET01878 | |
| 0.008 | 0.276 | 0.053 | Glutamate (mGluR group I) agonist | 0.053 0.028 DB12110 0.053 0.028 DBMET01878 | DBMET01878 | |
| 0.023 | 0.292 | 0.192 | ALK inhibitor | 0.192 0.012 DB12110 0.192 0.012 DBMET01878 | DBMET01878 | |
| 0.007 | 0.277 | 0.033 | Nicotinic acid receptor 2 agonist | 0.033 0.028 DBMET02168 | DBMET02168 | |
| 0.001 | 0.271 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET02168 | DBMET02168 | |
| 0.008 | 0.282 | 0.084 | NMDA 2A receptor antagonist | 0.084 0.018 DB12110 0.084 0.018 DBMET01878 | DBMET01878 | |
| 0.03 | 0.304 | 0.116 | GABA A receptor agonist | 0.076 0.07 DB12110 0.076 0.07 DBMET01878 0.116 0.026 DBMET01879 | DBMET01879 | |
| 0.036 | 0.311 | 0.188 | GABA C receptor rho-1 antagonist | 0.112 0.048 DBMET02182 0.17 0.014 DB12110 0.17 0.014 DBMET01878 0.188 0.01 DBMET01879 0.12 0.04 DBMET02168 0.09 0.078 DBMET02184 | DBMET01879 | |
| 0.031 | 0.306 | 0.077 | Neuropeptide Y antagonist | 0.077 0.063 DB12110 0.077 0.063 DBMET01878 | DBMET01878 | |
| 0.101 | 0.377 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 DB12110 0.147 0.052 DBMET01878 | DBMET01878 | |
| 0.045 | 0.323 | 0.342 | NADPH oxidase inhibitor | 0.342 0.008 DB12110 0.342 0.008 DBMET01878 | DBMET01878 | |
| 0.018 | 0.297 | 0.089 | Protein kinase C alpha inhibitor | 0.089 0.028 DB12110 0.089 0.028 DBMET01878 | DBMET01878 | |
| 0.002 | 0.281 | 0.118 | Egl nine homolog 3 inhibitor | 0.118 0.002 DBMET01879 | DBMET01879 | |
| 0.02 | 0.3 | 0.048 | CF transmembrane conductance regulator antagonist | 0.048 0.01 DB12110 0.048 0.01 DBMET01878 | DBMET01878 | |
| 0.06 | 0.342 | 0.18 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 DB12110 0.135 0.065 DBMET01878 0.18 0.015 DBMET01879 0.116 0.107 DBMET02168 | DBMET01879 | |
| 0.022 | 0.304 | 0.086 | Cathepsin G inhibitor | 0.069 0.055 DB12110 0.069 0.055 DBMET01878 0.086 0.04 DBMET02178 0.086 0.04 DBMET02183 | DBMET02183 | |
| 0.051 | 0.334 | 0.142 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET02182 0.142 0.072 DB12110 0.142 0.072 DBMET01878 0.135 0.079 DBMET01879 0.119 0.101 DBMET02170 0.116 0.109 DBMET02174 | DBMET01878 | |
| 0.01 | 0.295 | 0.109 | Toll-Like receptor 8 antagonist | 0.109 0.007 DB12110 0.109 0.007 DBMET01878 | DBMET01878 | |
| 0.086 | 0.372 | 0.275 | Gastrin inhibitor | 0.243 0.087 DBMET02182 0.226 0.11 DB12110 0.226 0.11 DBMET01878 0.235 0.098 DBMET01879 0.197 0.153 DBMET02168 0.212 0.131 DBMET02170 0.192 0.162 DBMET02184 0.207 0.138 DBMET02173 0.275 0.053 DBMET02174 | DBMET02174 | |
| 0.015 | 0.302 | 0.049 | Transforming growth factor beta 1 antagonist | 0.049 0.035 DB12110 0.049 0.035 DBMET01878 | DBMET01878 | |
| 0.027 | 0.315 | 0.257 | Cholesterol synthesis inhibitor | 0.257 0.017 DBMET01879 0.096 0.093 DBMET02178 0.096 0.093 DBMET02183 | DBMET01879 | |
| 0.077 | 0.367 | 0.153 | Death-associated protein kinase 1 inhibitor | 0.153 0.035 DB12110 0.153 0.035 DBMET01878 | DBMET01878 | |
| 0.005 | 0.296 | 0.055 | Glycine transporter inhibitor | 0.055 0.028 DB12110 0.055 0.028 DBMET01878 | DBMET01878 | |
| 0.016 | 0.309 | 0.107 | Cyclin-dependent kinase 4 inhibitor | 0.107 0.024 DB12110 0.107 0.024 DBMET01878 | DBMET01878 | |
| 0.01 | 0.303 | 0.307 | Neurokinin antagonist | 0.307 0.004 DBMET02168 0.238 0.004 DBMET02170 | DBMET02168 | |
| 0.138 | 0.432 | 0.226 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.226 0.103 DB12110 0.226 0.103 DBMET01878 | DBMET01878 | |
| 0.021 | 0.315 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | 0.085 0.011 DB12110 0.085 0.011 DBMET01878 | DBMET01878 | |
| 0.004 | 0.299 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DB12110 0.033 0.015 DBMET01878 | DBMET01878 | |
| 0.011 | 0.307 | 0.088 | Adenosine deaminase inhibitor | 0.049 0.031 DBMET02182 0.088 0.007 DBMET01879 0.043 0.037 DBMET02184 | DBMET01879 | |
| 0.028 | 0.324 | 0.184 | Bronchodilator | 0.184 0.021 DBMET02169 0.12 0.044 DBMET02175 0.106 0.057 DBMET02177 0.132 0.039 DBMET02178 0.132 0.039 DBMET02183 0.088 0.077 DBMET02184 | DBMET02169 | |
| 0.003 | 0.3 | 0.019 | Complement factor D inhibitor | 0.019 0.011 DB12110 0.019 0.011 DBMET01878 | DBMET01878 | |
| 0.041 | 0.337 | 0.152 | Activin receptor-like kinase 4 inhibitor | 0.152 0.028 DB12110 0.152 0.028 DBMET01878 | DBMET01878 | |
| 0.02 | 0.317 | 0.068 | Cyclin H inhibitor | 0.068 0.03 DB12110 0.068 0.03 DBMET01878 | DBMET01878 | |
| 0.004 | 0.302 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | 0.03 0.028 DBMET02182 | DBMET02182 | |
| 0.087 | 0.386 | 0.713 | 5 Hydroxytryptamine release stimulant | 0.713 0.006 DB12110 0.713 0.006 DBMET01878 0.175 0.146 DBMET02168 | DBMET01878 | |
| 0.072 | 0.371 | 0.239 | Calpain 2 inhibitor | 0.239 0.157 DB12110 0.239 0.157 DBMET01878 | DBMET01878 | |
| 0.016 | 0.316 | 0.195 | Sphingosine 1-phosphate receptor 5 agonist | 0.124 0.005 DBMET02182 0.195 0.004 DBMET01879 0.097 0.009 DBMET02178 0.097 0.009 DBMET02183 0.054 0.037 DBMET02184 0.093 0.009 DBMET02174 | DBMET01879 | |
| 0.005 | 0.307 | 0.032 | Myristoyl transferase inhibitor | 0.032 0.011 DB12110 0.032 0.011 DBMET01878 | DBMET01878 | |
| 0.042 | 0.346 | 0.146 | Hedgehog signaling inhibitor | 0.146 0.025 DB12110 0.146 0.025 DBMET01878 | DBMET01878 | |
| 0.053 | 0.358 | 0.329 | Interleukin agonist | 0.329 0.036 DB12110 0.329 0.036 DBMET01878 0.224 0.099 DBMET01879 | DBMET01878 | |
| 0.014 | 0.319 | 0.055 | Thymidine kinase inhibitor | 0.055 0.015 DBMET01879 0.038 0.033 DBMET02168 | DBMET01879 | |
| 0.035 | 0.341 | 0.243 | Amylase inhibitor | 0.111 0.087 DBMET02182 0.115 0.084 DB12110 0.115 0.084 DBMET01878 0.125 0.078 DBMET01879 0.243 0.03 DBMET02169 0.226 0.035 DBMET02168 0.173 0.054 DBMET02170 | DBMET02169 | |
| 0.138 | 0.445 | 0.436 | Caspase 9 stimulant | 0.436 0.091 DB12110 0.436 0.091 DBMET01878 0.278 0.219 DBMET01879 | DBMET01878 | |
| 0.085 | 0.394 | 0.268 | Neuropeptide Y2 antagonist | 0.268 0.04 DB12110 0.268 0.04 DBMET01878 | DBMET01878 | |
| 0.003 | 0.313 | 0.025 | 5 Hydroxytryptamine 1D agonist | 0.025 0.023 DB12110 0.025 0.023 DBMET01878 | DBMET01878 | |
| 0.014 | 0.325 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.035 DB12110 0.042 0.035 DBMET01878 0.042 0.037 DBMET02168 | DBMET02168 | |
| 0.037 | 0.348 | 0.098 | Calcium channel (voltage-sensitive) blocker | 0.098 0.086 DB12110 0.098 0.086 DBMET01878 | DBMET01878 | |
| 0.033 | 0.346 | 0.116 | Bile acid receptor antagonist | 0.09 0.073 DB12110 0.09 0.073 DBMET01878 0.116 0.023 DBMET02174 | DBMET02174 | |
| 0.075 | 0.389 | 0.272 | DNA synthesis inhibitor | 0.245 0.07 DBMET02182 0.259 0.061 DB12110 0.259 0.061 DBMET01878 0.229 0.084 DBMET01879 0.272 0.055 DBMET02169 0.217 0.098 DBMET02168 0.209 0.109 DBMET02170 0.248 0.068 DBMET02178 0.248 0.068 DBMET02183 0.204 0.117 DBMET02184 0.195 0.13 DBMET02173 0.171 0.166 DBMET02174 | DBMET02169 | |
| 0.011 | 0.325 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | 0.061 0.019 DB12110 0.061 0.019 DBMET01878 | DBMET01878 | |
| 0.014 | 0.329 | 0.051 | Myc inhibitor | 0.051 0.043 DB12110 0.051 0.043 DBMET01878 | DBMET01878 | |
| 0.003 | 0.318 | 0.012 | Egl nine homolog 2 inhibitor | 0.012 0.008 DBMET01879 | DBMET01879 | |
| 0.02 | 0.335 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.073 DB12110 0.098 0.073 DBMET01878 | DBMET01878 | |
| 0.012 | 0.33 | 0.072 | Amidase inhibitor | 0.072 0.045 DB12110 0.072 0.045 DBMET01878 | DBMET01878 | |
| 0.02 | 0.342 | 0.184 | Phosphodiesterase 3A inhibitor | 0.184 0.01 DBMET02168 0.12 0.022 DBMET02170 | DBMET02168 | |
| 0.015 | 0.339 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DB12110 0.059 0.043 DBMET01878 | DBMET01878 | |
| 0.016 | 0.339 | 0.099 | Insulin like growth factor 1 antagonist | 0.099 0.042 DB12110 0.099 0.042 DBMET01878 | DBMET01878 | |
| 0.004 | 0.328 | 0.05 | Urate transporter 1 inhibitor | 0.042 0.024 DBMET02182 0.05 0.019 DBMET01879 | DBMET01879 | |
| 0.066 | 0.391 | 0.197 | ATPase inhibitor | 0.197 0.04 DB12110 0.197 0.04 DBMET01878 | DBMET01878 | |
| 0.006 | 0.331 | 0.314 | Neurokinin 1 antagonist | 0.314 0.004 DBMET02168 0.267 0.004 DBMET02170 | DBMET02168 | |
| 0.033 | 0.36 | 0.102 | Vanilloid 4 agonist | 0.102 0.015 DB12110 0.102 0.015 DBMET01878 | DBMET01878 | |
| 0.078 | 0.405 | 0.275 | Cholesterol antagonist | 0.218 0.149 DBMET02182 0.275 0.108 DB12110 0.275 0.108 DBMET01878 0.235 0.136 DBMET01879 0.186 0.178 DBMET02178 0.186 0.178 DBMET02183 | DBMET01878 | |
| 0.013 | 0.341 | 0.069 | GABA B receptor antagonist | 0.069 0.009 DB12110 0.069 0.009 DBMET01878 0.044 0.028 DBMET01879 | DBMET01878 | |
| 0.047 | 0.376 | 0.284 | Transforming growth factor beta 3 antagonist | 0.284 0.003 DBMET02179 0.085 0.049 DB12110 0.085 0.049 DBMET01878 0.208 0.004 DBMET02177 | DBMET02179 | |
| 0.027 | 0.357 | 0.159 | Exportin-1 inhibitor | 0.091 0.014 DB12110 0.091 0.014 DBMET01878 0.159 0.003 DBMET01879 | DBMET01879 | |
| 0.01 | 0.34 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.088 0.016 DB12110 0.088 0.016 DBMET01878 | DBMET01878 | |
| 0.021 | 0.353 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 DB12110 0.046 0.04 DBMET01878 | DBMET01878 | |
| 0.005 | 0.338 | 0.039 | Kinesin-like protein 1 inhibitor | 0.039 0.023 DBMET02174 | DBMET02174 | |
| 0.005 | 0.338 | 0.039 | Kinesin antagonist | 0.039 0.023 DBMET02174 | DBMET02174 | |
| 0.031 | 0.364 | 0.114 | Nav1.6 sodium channel blocker | 0.114 0.105 DB12110 0.114 0.105 DBMET01878 | DBMET01878 | |
| 0.006 | 0.341 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 DB12110 0.03 0.023 DBMET01878 | DBMET01878 | |
| 0.039 | 0.374 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.035 DB12110 0.083 0.035 DBMET01878 | DBMET01878 | |
| 0.016 | 0.351 | 0.061 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 DB12110 0.053 0.025 DBMET01878 0.061 0.014 DBMET01879 | DBMET01879 | |
| 0.015 | 0.35 | 0.106 | Insulin growth factor antagonist | 0.106 0.043 DB12110 0.106 0.043 DBMET01878 | DBMET01878 | |
| 0.011 | 0.346 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.042 0.036 DB12110 0.042 0.036 DBMET01878 0.047 0.027 DBMET02168 | DBMET02168 | |
| 0.009 | 0.346 | 0.11 | Nicotinic neuronal receptor agonist | 0.11 0.01 DB12110 0.11 0.01 DBMET01878 | DBMET01878 | |
| 0.011 | 0.348 | 0.184 | Biliverdin reductase inhibitor | 0.172 0.007 DBMET02182 0.184 0.007 DBMET01879 0.114 0.015 DBMET02169 0.076 0.028 DBMET02168 0.061 0.039 DBMET02170 0.136 0.011 DBMET02178 0.136 0.011 DBMET02183 0.079 0.027 DBMET02174 | DBMET01879 | |
| 0.005 | 0.344 | 0.17 | NMDA 2 receptor antagonist | 0.17 0.013 DB12110 0.17 0.013 DBMET01878 | DBMET01878 | |
| 0.011 | 0.354 | 0.059 | Nicotinic alpha7 receptor agonist | 0.059 0.032 DB12110 0.059 0.032 DBMET01878 | DBMET01878 | |
| 0.02 | 0.364 | 0.164 | Glycine receptor antagonist | 0.164 0.005 DB12110 0.164 0.005 DBMET01878 | DBMET01878 | |
| 0.029 | 0.377 | 0.117 | GABA B receptor agonist | 0.111 0.01 DB12110 0.111 0.01 DBMET01878 0.117 0.008 DBMET01879 0.081 0.039 DBMET02174 | DBMET01879 | |
| 0.101 | 0.449 | 0.314 | Tyrosine 3 hydroxylase inhibitor | 0.265 0.055 DBMET02182 0.279 0.045 DB12110 0.279 0.045 DBMET01878 0.314 0.027 DBMET01879 0.2 0.135 DBMET02169 0.285 0.041 DBMET02168 0.286 0.041 DBMET02170 0.21 0.118 DBMET02178 0.21 0.118 DBMET02183 0.193 0.149 DBMET02184 0.198 0.139 DBMET02173 0.263 0.056 DBMET02174 | DBMET01879 | |
| 0.022 | 0.372 | 0.09 | Myeloperoxidase inhibitor | 0.09 0.049 DB12110 0.09 0.049 DBMET01878 0.078 0.071 DBMET02168 | DBMET01878 | |
| 0.006 | 0.356 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DB12110 0.057 0.013 DBMET01878 | DBMET01878 | |
| 0.003 | 0.355 | 0.092 | Nicotinic alpha4 receptor agonist | 0.092 0.003 DB12110 0.092 0.003 DBMET01878 | DBMET01878 | |
| 0.048 | 0.402 | 0.196 | Hexokinase inhibitor | 0.196 0.037 DB12110 0.196 0.037 DBMET01878 | DBMET01878 | |
| 0.015 | 0.37 | 0.154 | Purinergic P2X4 antagonist | 0.154 0.004 DB12110 0.154 0.004 DBMET01878 | DBMET01878 | |
| 0.021 | 0.378 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DB12110 0.074 0.019 DBMET01878 | DBMET01878 | |
| 0.026 | 0.384 | 0.072 | Viral attachment inhibitor | 0.072 0.069 DB12110 0.072 0.069 DBMET01878 | DBMET01878 | |
| 0.008 | 0.366 | 0.036 | Melanocortin 1 antagonist | 0.036 0.029 DB12110 0.036 0.029 DBMET01878 | DBMET01878 | |
| 0.011 | 0.374 | 0.036 | Protein kinase (CK2) beta inhibitor | 0.036 0.017 DB12110 0.036 0.017 DBMET01878 0.034 0.022 DBMET01879 | DBMET01878 | |
| 0.018 | 0.381 | 0.225 | Alcohol dehydrogenase inhibitor | 0.138 0.025 DBMET02182 0.225 0.01 DBMET01879 0.086 0.069 DBMET02168 0.083 0.074 DBMET02178 0.083 0.074 DBMET02183 0.087 0.069 DBMET02174 | DBMET01879 | |
| 0.007 | 0.37 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET02182 0.022 0.005 DBMET01879 0.018 0.012 DBMET02178 0.018 0.012 DBMET02183 | DBMET01879 | |
| 0.025 | 0.388 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.102 0.058 DBMET02182 0.1 0.061 DB12110 0.1 0.061 DBMET01878 0.091 0.072 DBMET01879 0.159 0.026 DBMET02169 0.13 0.037 DBMET02168 0.159 0.026 DBMET02170 0.095 0.067 DBMET02178 0.095 0.067 DBMET02183 | DBMET02170 | |
| 0.022 | 0.386 | 0.205 | DNA intercalator | 0.205 0.024 DBMET01879 | DBMET01879 | |
| 0.006 | 0.371 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DB12110 0.03 0.022 DBMET01878 | DBMET01878 | |
| 0.02 | 0.387 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.029 DB12110 0.053 0.029 DBMET01878 | DBMET01878 | |
| 0.005 | 0.371 | 0.044 | Prostacyclin antagonist | 0.031 0.025 DBMET02182 0.044 0.015 DBMET01879 | DBMET01879 | |
| 0.01 | 0.377 | 0.06 | Androgen agonist | 0.06 0.041 DB12110 0.06 0.041 DBMET01878 | DBMET01878 | |
| 0.015 | 0.382 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 DB12110 0.05 0.042 DBMET01878 | DBMET01878 | |
| 0.023 | 0.391 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 DB12110 0.148 0.033 DBMET01878 0.115 0.056 DBMET01879 | DBMET01878 | |
| 0.08 | 0.447 | 0.22 | RNA-directed DNA polymerase inhibitor | 0.173 0.145 DBMET02182 0.21 0.086 DB12110 0.21 0.086 DBMET01878 0.181 0.13 DBMET02169 0.22 0.074 DBMET02168 0.206 0.091 DBMET02170 0.196 0.106 DBMET02184 0.181 0.131 DBMET02173 | DBMET02168 | |
| 0.026 | 0.394 | 0.131 | Uric acid excretion stimulant | 0.103 0.049 DBMET02182 0.131 0.032 DBMET01879 | DBMET01879 | |
| 0.01 | 0.379 | 0.06 | EphB4 antagonist | 0.06 0.038 DB12110 0.06 0.038 DBMET01878 | DBMET01878 | |
| 0.006 | 0.38 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.063 0.01 DB12110 0.063 0.01 DBMET01878 0.055 0.013 DBMET01879 0.035 0.032 DBMET02168 | DBMET01878 | |
| 0.05 | 0.425 | 0.183 | Pregnane X receptor agonist | 0.183 0.017 DB12110 0.183 0.017 DBMET01878 | DBMET01878 | |
| 0.089 | 0.465 | 0.461 | Calcium channel activator | 0.461 0.009 DB12110 0.461 0.009 DBMET01878 0.213 0.195 DBMET02168 | DBMET01878 | |
| 0.023 | 0.4 | 0.325 | Ephrin antagonist | 0.325 0.008 DBMET02179 0.288 0.01 DBMET02177 | DBMET02179 | |
| 0.023 | 0.399 | 0.198 | GABA C receptor antagonist | 0.11 0.064 DBMET02182 0.183 0.017 DB12110 0.183 0.017 DBMET01878 0.198 0.013 DBMET01879 0.151 0.029 DBMET02168 0.108 0.067 DBMET02170 | DBMET01879 | |
| 0.007 | 0.384 | 0.779 | Macrophage elastase inhibitor | 0.779 0.002 DBMET02168 0.466 0.003 DBMET02170 | DBMET02168 | |
| 0.025 | 0.402 | 0.08 | Glycine receptor agonist | 0.068 0.059 DBMET02182 0.08 0.039 DB12110 0.08 0.039 DBMET01878 0.067 0.061 DBMET01879 0.077 0.042 DBMET02173 | DBMET01878 | |
| 0.012 | 0.389 | 0.168 | Acetylcholine nicotinic agonist | 0.168 0.012 DB12110 0.168 0.012 DBMET01878 | DBMET01878 | |
| 0.03 | 0.408 | 0.125 | Cathepsin H inhibitor | 0.109 0.09 DB12110 0.109 0.09 DBMET01878 0.12 0.075 DBMET02168 0.125 0.069 DBMET02170 | DBMET02170 | |
| 0.011 | 0.389 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.06 0.036 DB12110 0.06 0.036 DBMET01878 | DBMET01878 | |
| 0.016 | 0.395 | 0.048 | Guanylate cyclase stimulant | 0.046 0.026 DBMET02169 0.048 0.023 DBMET02168 0.041 0.036 DBMET02170 | DBMET02168 | |
| 0.014 | 0.395 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 DB12110 0.059 0.03 DBMET01878 | DBMET01878 | |
| 0.004 | 0.385 | 0.054 | Imidazoline I1 receptor antagonist | 0.054 0.004 DB12110 0.054 0.004 DBMET01878 | DBMET01878 | |
| 0.006 | 0.388 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.018 DB12110 0.02 0.018 DBMET01878 | DBMET01878 | |
| 0.041 | 0.426 | 0.097 | T cell inhibitor | 0.097 0.028 DB12110 0.097 0.028 DBMET01878 | DBMET01878 | |
| 0.007 | 0.395 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 DB12110 0.09 0.01 DBMET01878 | DBMET01878 | |
| 0.01 | 0.4 | 0.506 | Thromboxane synthase inhibitor | 0.05 0.048 DBMET02182 0.506 0.002 DBMET01879 | DBMET01879 | |
| 0.031 | 0.424 | 0.111 | Calcium channel blocker | 0.111 0.098 DB12110 0.111 0.098 DBMET01878 | DBMET01878 | |
| 0.006 | 0.401 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 DB12110 0.112 0.012 DBMET01878 | DBMET01878 | |
| 0.008 | 0.403 | 0.137 | Acyl-CoA dehydrogenase inhibitor | 0.083 0.021 DBMET02182 0.137 0.01 DBMET01879 0.079 0.022 DBMET02169 0.072 0.026 DBMET02178 0.072 0.026 DBMET02183 | DBMET01879 | |
| 0.02 | 0.417 | 0.099 | Caspase 7 inhibitor | 0.099 0.029 DB12110 0.099 0.029 DBMET01878 0.086 0.048 DBMET01879 | DBMET01878 | |
| 0.009 | 0.41 | 0.077 | Cyclin A1 inhibitor | 0.077 0.016 DB12110 0.077 0.016 DBMET01878 | DBMET01878 | |
| 0.043 | 0.448 | 0.113 | Glutamate release inhibitor | 0.113 0.027 DB12110 0.113 0.027 DBMET01878 | DBMET01878 | |
| 0.006 | 0.411 | 0.207 | Glutamate (mGluR3) antagonist | 0.034 0.03 DB12110 0.034 0.03 DBMET01878 0.207 0.003 DBMET01879 | DBMET01879 | |
| 0.104 | 0.514 | 0.419 | 5 Hydroxytryptamine uptake stimulant | 0.419 0.011 DB12110 0.419 0.011 DBMET01878 0.226 0.109 DBMET01879 0.229 0.104 DBMET02168 0.232 0.101 DBMET02170 0.253 0.078 DBMET02174 | DBMET01878 | |
| 0.018 | 0.429 | 0.074 | Dihydroorotate oxidase inhibitor | 0.062 0.027 DBMET02169 0.071 0.016 DBMET02168 0.074 0.014 DBMET02170 | DBMET02170 | |
| 0.009 | 0.423 | 0.064 | CDK4/cyclin D inhibitor | 0.064 0.033 DB12110 0.064 0.033 DBMET01878 | DBMET01878 | |
| 0.039 | 0.456 | 0.253 | Adenylate kinase inhibitor | 0.196 0.015 DBMET02182 0.253 0.01 DBMET01879 0.253 0.01 DBMET02169 0.132 0.035 DBMET02168 0.129 0.037 DBMET02170 0.242 0.01 DBMET02178 0.242 0.01 DBMET02183 0.099 0.068 DBMET02184 0.094 0.078 DBMET02173 0.12 0.044 DBMET02174 | DBMET02169 | |
| 0.013 | 0.43 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 DB12110 0.064 0.023 DBMET01878 | DBMET01878 | |
| 0.009 | 0.427 | 0.077 | Cyclin B1 inhibitor | 0.077 0.025 DB12110 0.077 0.025 DBMET01878 | DBMET01878 | |
| 0.032 | 0.453 | 0.109 | Cell adhesion inhibitor | 0.109 0.076 DBMET02174 | DBMET02174 | |
| 0.007 | 0.429 | 0.065 | Cyclin B2 inhibitor | 0.065 0.027 DB12110 0.065 0.027 DBMET01878 | DBMET01878 | |
| 0.007 | 0.429 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 DB12110 0.103 0.015 DBMET01878 | DBMET01878 | |
| 0.002 | 0.428 | 0.014 | Egl nine homolog 1 inhibitor | 0.014 0.011 DBMET01879 | DBMET01879 | |
| 0.006 | 0.432 | 0.02 | Factor XIII inhibitor | 0.02 0.017 DB12110 0.02 0.017 DBMET01878 | DBMET01878 | |
| 0.006 | 0.433 | 0.032 | CDK4/cyclin D3 inhibitor | 0.032 0.016 DB12110 0.032 0.016 DBMET01878 | DBMET01878 | |
| 0.067 | 0.497 | 0.334 | Vasodilator, peripheral | 0.334 0.081 DB12110 0.334 0.081 DBMET01878 0.202 0.174 DBMET02169 | DBMET01878 | |
| 0.02 | 0.453 | 0.197 | Glutamate dehydrogenase inhibitor | 0.143 0.017 DBMET02182 0.197 0.01 DBMET01879 0.091 0.036 DBMET02169 0.069 0.058 DBMET02168 0.128 0.02 DBMET02178 0.128 0.02 DBMET02183 0.088 0.038 DBMET02174 | DBMET01879 | |
| 0.007 | 0.441 | 0.078 | CDK4/cyclin D1 inhibitor | 0.078 0.025 DB12110 0.078 0.025 DBMET01878 | DBMET01878 | |
| 0.03 | 0.463 | 0.393 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET02182 0.117 0.103 DB12110 0.117 0.103 DBMET01878 0.393 0.006 DBMET01879 0.225 0.022 DBMET02169 0.139 0.076 DBMET02168 0.147 0.068 DBMET02170 0.213 0.025 DBMET02178 0.213 0.025 DBMET02183 | DBMET01879 | |
| 0.066 | 0.5 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 DB12110 0.191 0.04 DBMET01878 0.149 0.105 DBMET01879 | DBMET01878 | |
| 0.013 | 0.448 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 DB12110 0.117 0.087 DBMET01878 | DBMET01878 | |
| 0.014 | 0.45 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.025 DBMET01879 | DBMET01879 | |
| 0.004 | 0.442 | 0.03 | Calcium-sensing receptor agonist | 0.03 0.013 DB12110 0.03 0.013 DBMET01878 | DBMET01878 | |
| 0.038 | 0.476 | 0.129 | Thiol protease inhibitor | 0.129 0.099 DB12110 0.129 0.099 DBMET01878 | DBMET01878 | |
| 0.02 | 0.461 | 0.098 | Estrogen receptor beta antagonist | 0.098 0.069 DBMET02180 | DBMET02180 | |
| 0.004 | 0.445 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DB12110 0.066 0.033 DBMET01878 | DBMET01878 | |
| 0.029 | 0.471 | 0.106 | Estrogen antagonist | 0.106 0.084 DBMET02180 | DBMET02180 | |
| 0.049 | 0.491 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.074 DB12110 0.146 0.074 DBMET01878 | DBMET01878 | |
| 0.011 | 0.454 | 0.065 | CDK1/cyclin B1 inhibitor | 0.065 0.054 DB12110 0.065 0.054 DBMET01878 | DBMET01878 | |
| 0.009 | 0.453 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET01879 | DBMET01879 | |
| 0.004 | 0.448 | 0.052 | Nicotinic acid receptor 2 antagonist | 0.026 0.019 DBMET02169 0.052 0.004 DBMET02168 0.035 0.008 DBMET02170 | DBMET02168 | |
| 0.014 | 0.458 | 0.102 | GABA aminotransferase inhibitor | 0.102 0.026 DBMET01879 0.074 0.054 DBMET02168 | DBMET01879 | |
| 0.007 | 0.452 | 0.065 | Cyclin B inhibitor | 0.065 0.026 DB12110 0.065 0.026 DBMET01878 | DBMET01878 | |
| 0.008 | 0.454 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 DB12110 0.053 0.021 DBMET01878 | DBMET01878 | |
| 0.016 | 0.464 | 0.092 | Falcipain 3 inhibitor | 0.092 0.079 DB12110 0.092 0.079 DBMET01878 | DBMET01878 | |
| 0.005 | 0.454 | 0.208 | Phosphodiesterase 3B inhibitor | 0.208 0.005 DBMET02168 0.119 0.008 DBMET02170 | DBMET02168 | |
| 0.053 | 0.503 | 0.295 | Antithrombotic | 0.267 0.113 DBMET02182 0.194 0.185 DB12110 0.194 0.185 DBMET01878 0.287 0.097 DBMET01879 0.29 0.095 DBMET02178 0.29 0.095 DBMET02183 0.216 0.158 DBMET02184 0.191 0.189 DBMET02173 0.295 0.091 DBMET02174 | DBMET02174 | |
| 0.01 | 0.464 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 DB12110 0.064 0.027 DBMET01878 | DBMET01878 | |
| 0.065 | 0.518 | 0.268 | Vasodilator, coronary | 0.268 0.117 DB12110 0.268 0.117 DBMET01878 | DBMET01878 | |
| 0.012 | 0.466 | 0.046 | Kainate receptor agonist | 0.041 0.028 DBMET02182 0.046 0.02 DBMET01879 0.041 0.028 DBMET02168 | DBMET01879 | |
| 0.008 | 0.464 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 DB12110 0.141 0.007 DBMET01878 | DBMET01878 | |
| 0.041 | 0.498 | 0.189 | Adenylate cyclase stimulant | 0.141 0.078 DBMET02182 0.154 0.056 DB12110 0.154 0.056 DBMET01878 0.189 0.019 DBMET01879 0.157 0.052 DBMET02178 0.157 0.052 DBMET02183 0.139 0.083 DBMET02174 | DBMET01879 | |
| 0.009 | 0.468 | 0.15 | Glutamate decarboxylase inhibitor | 0.13 0.018 DBMET02182 0.15 0.013 DBMET01879 0.121 0.02 DBMET02169 0.07 0.055 DBMET02168 0.075 0.049 DBMET02170 0.149 0.013 DBMET02178 0.149 0.013 DBMET02183 0.093 0.034 DBMET02174 | DBMET01879 | |
| 0.004 | 0.465 | 0.047 | Protein kinase (CK1) epsilon inhibitor | 0.047 0.016 DB12110 0.047 0.016 DBMET01878 | DBMET01878 | |
| 0.017 | 0.48 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 DB12110 0.124 0.039 DBMET01878 | DBMET01878 | |
| 0.004 | 0.469 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 DB12110 0.034 0.024 DBMET01878 | DBMET01878 | |
| 0.027 | 0.493 | 0.107 | DOPA decarboxylase inhibitor | 0.095 0.087 DBMET02182 0.107 0.062 DBMET01879 | DBMET01879 | |
| 0.012 | 0.48 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.034 DBMET02168 | DBMET02168 | |
| 0.004 | 0.472 | 0.029 | Prostaglandin D2 agonist | 0.029 0.024 DBMET02178 0.029 0.024 DBMET02183 | DBMET02183 | |
| 0.014 | 0.483 | 0.06 | Fatty acid synthase inhibitor | 0.06 0.036 DBMET02168 0.056 0.041 DBMET02170 | DBMET02168 | |
| 0.024 | 0.493 | 0.174 | Triose-phosphate isomerase inhibitor | 0.141 0.023 DBMET02182 0.167 0.016 DBMET01879 0.135 0.025 DBMET02169 0.174 0.014 DBMET02178 0.174 0.014 DBMET02183 0.09 0.06 DBMET02174 | DBMET02183 | |
| 0.014 | 0.483 | 0.145 | Glutamate (mGluR4) antagonist | 0.04 0.037 DBMET02182 0.145 0.004 DBMET01879 | DBMET01879 | |
| 0.009 | 0.482 | 0.281 | Porphobilinogen synthase inhibitor | 0.174 0.016 DBMET02182 0.281 0.006 DBMET01879 0.083 0.045 DBMET02169 0.069 0.056 DBMET02168 0.099 0.036 DBMET02178 0.099 0.036 DBMET02183 0.072 0.054 DBMET02174 | DBMET01879 | |
| 0.043 | 0.517 | 0.158 | Interferon gamma antagonist | 0.125 0.122 DBMET02182 0.158 0.068 DBMET01879 0.127 0.117 DBMET02178 0.127 0.117 DBMET02183 0.134 0.103 DBMET02173 0.137 0.098 DBMET02174 | DBMET01879 | |
| 0.011 | 0.485 | 0.085 | NMDA receptor agonist | 0.085 0.026 DB12110 0.085 0.026 DBMET01878 | DBMET01878 | |
| 0.007 | 0.481 | 0.027 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET02182 0.027 0.013 DBMET01879 | DBMET01879 | |
| 0.003 | 0.48 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 DB12110 0.018 0.008 DBMET01878 | DBMET01878 | |
| 0.006 | 0.484 | 0.111 | Protein kinase (CK2) inhibitor | 0.111 0.054 DBMET01879 | DBMET01879 | |
| 0.009 | 0.488 | 0.038 | Leukotriene C4 antagonist | 0.037 0.035 DBMET01879 0.038 0.031 DBMET02174 | DBMET02174 | |
| 0.003 | 0.482 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.033 0.026 DB12110 0.033 0.026 DBMET01878 | DBMET01878 | |
| 0.014 | 0.493 | 0.058 | Leukotriene C antagonist | 0.057 0.036 DBMET01879 0.058 0.034 DBMET02174 | DBMET02174 | |
| 0.031 | 0.511 | 0.464 | Peroxidase inhibitor | 0.122 0.098 DBMET02182 0.174 0.067 DB12110 0.174 0.067 DBMET01878 0.281 0.041 DBMET01879 0.464 0.013 DBMET02169 0.207 0.057 DBMET02168 0.231 0.052 DBMET02170 0.198 0.06 DBMET02178 0.198 0.06 DBMET02183 | DBMET02169 | |
| 0.005 | 0.486 | 0.065 | Prostaglandin EP2 antagonist | 0.065 0.037 DBMET01879 0.051 0.05 DBMET02178 0.051 0.05 DBMET02183 | DBMET01879 | |
| 0.003 | 0.487 | 0.094 | Geranyltranstransferase inhibitor | 0.094 0.004 DBMET01879 | DBMET01879 | |
| 0.011 | 0.496 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET01879 0.078 0.041 DBMET02168 | DBMET01879 | |
| 0.005 | 0.491 | 0.178 | Protein kinase (CK2) alpha inhibitor | 0.178 0.03 DBMET01879 | DBMET01879 | |
| 0.016 | 0.503 | 0.088 | Cell adhesion molecule inhibitor | 0.088 0.044 DBMET02174 | DBMET02174 | |
| 0.005 | 0.492 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 DB12110 0.083 0.016 DBMET01878 | DBMET01878 | |
| 0.007 | 0.495 | 0.194 | Check point kinase 1 inhibitor | 0.087 0.034 DB12110 0.087 0.034 DBMET01878 0.072 0.044 DBMET02169 0.194 0.01 DBMET02168 0.187 0.01 DBMET02170 | DBMET02168 | |
| 0.012 | 0.501 | 0.112 | Calcium antagonist | 0.112 0.039 DB12110 0.112 0.039 DBMET01878 | DBMET01878 | |
| 0.049 | 0.538 | 0.165 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.165 0.125 DB12110 0.165 0.125 DBMET01878 | DBMET01878 | |
| 0.001 | 0.492 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET01879 | DBMET01879 | |
| 0.006 | 0.497 | 0.169 | Alcohol oxidase inhibitor | 0.083 0.023 DBMET02182 0.169 0.008 DBMET01879 0.117 0.015 DBMET02169 0.064 0.033 DBMET02168 0.065 0.032 DBMET02170 0.072 0.028 DBMET02178 0.072 0.028 DBMET02183 | DBMET01879 | |
| 0.022 | 0.515 | 0.119 | Nav1.5 sodium channel blocker | 0.119 0.055 DB12110 0.119 0.055 DBMET01878 | DBMET01878 | |
| 0.032 | 0.528 | 0.275 | Vasodilator | 0.275 0.057 DBMET02168 | DBMET02168 | |
| 0.005 | 0.503 | 0.014 | Integrin beta6 antagonist | 0.014 0.01 DBMET01879 | DBMET01879 | |
| 0.018 | 0.518 | 0.088 | Factor XII inhibitor | 0.088 0.052 DBMET02168 0.086 0.055 DBMET02170 | DBMET02168 | |
| 0.005 | 0.505 | 0.024 | Geranylgeranyltransferase inhibitor | 0.024 0.013 DB12110 0.024 0.013 DBMET01878 | DBMET01878 | |
| 0.016 | 0.517 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 DB12110 0.064 0.045 DBMET01878 | DBMET01878 | |
| 0.013 | 0.513 | 0.056 | MAP kinase kinase 9 inhibitor | 0.056 0.038 DB12110 0.056 0.038 DBMET01878 | DBMET01878 | |
| 0.018 | 0.52 | 0.138 | Aminopeptidase B inhibitor | 0.134 0.045 DBMET02182 0.138 0.043 DBMET01879 0.096 0.068 DBMET02178 0.096 0.068 DBMET02183 | DBMET01879 | |
| 0.006 | 0.509 | 0.049 | Mannosidase inhibitor | 0.049 0.026 DBMET01879 | DBMET01879 | |
| 0.004 | 0.508 | 0.023 | Integrin alphaVbeta3 antagonist | 0.023 0.014 DBMET01879 | DBMET01879 | |
| 0.003 | 0.508 | 0.061 | Glutamate (mGluR group II) antagonist | 0.061 0.011 DBMET01879 | DBMET01879 | |
| 0.003 | 0.507 | 0.036 | Glutamate (mGluR2) antagonist | 0.036 0.014 DBMET01879 | DBMET01879 | |
| 0.016 | 0.521 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.033 DBMET01879 | DBMET01879 | |
| 0.005 | 0.512 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 DB12110 0.045 0.028 DBMET01878 | DBMET01878 | |
| 0.037 | 0.544 | 0.189 | DNA damaging | 0.189 0.125 DB12110 0.189 0.125 DBMET01878 | DBMET01878 | |
| 0.036 | 0.545 | 0.222 | Focal adhesion kinase 2 inhibitor | 0.222 0.053 DB12110 0.222 0.053 DBMET01878 | DBMET01878 | |
| 0.006 | 0.515 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.024 DBMET01879 | DBMET01879 | |
| 0.001 | 0.511 | 0.011 | Imidazoline I2 receptor antagonist | 0.011 0.008 DB12110 0.011 0.008 DBMET01878 | DBMET01878 | |
| 0.021 | 0.532 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 DB12110 0.171 0.12 DBMET01878 | DBMET01878 | |
| 0.015 | 0.528 | 0.078 | Purinergic P2X1 antagonist | 0.078 0.026 DBMET01879 0.059 0.045 DBMET02170 | DBMET01879 | |
| 0.038 | 0.552 | 0.249 | 15-Lipoxygenase inhibitor | 0.228 0.184 DB12110 0.228 0.184 DBMET01878 0.249 0.165 DBMET01879 | DBMET01879 | |
| 0.009 | 0.523 | 0.437 | 5-Lipoxygenase inhibitor | 0.082 0.078 DBMET02169 0.399 0.005 DBMET02168 0.437 0.005 DBMET02170 | DBMET02170 | |
| 0.007 | 0.522 | 0.092 | Catalase inhibitor | 0.071 0.054 DBMET02182 0.076 0.05 DBMET01879 0.092 0.042 DBMET02178 0.092 0.042 DBMET02183 0.087 0.044 DBMET02174 | DBMET02183 | |
| 0.002 | 0.521 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.037 0.004 DB12110 0.037 0.004 DBMET01878 | DBMET01878 | |
| 0.008 | 0.528 | 0.107 | Histidine decarboxylase inhibitor | 0.107 0.029 DBMET01879 | DBMET01879 | |
| 0.012 | 0.533 | 0.062 | Glutamate (mGluR7) antagonist | 0.062 0.061 DBMET01879 | DBMET01879 | |
| 0.021 | 0.543 | 0.167 | Arachidonic acid antagonist | 0.132 0.11 DB12110 0.132 0.11 DBMET01878 0.167 0.069 DBMET01879 0.14 0.101 DBMET02168 0.165 0.071 DBMET02170 0.137 0.103 DBMET02174 | DBMET01879 | |
| 0.028 | 0.55 | 0.179 | DNA methylase inhibitor | 0.179 0.094 DB12110 0.179 0.094 DBMET01878 0.179 0.093 DBMET01879 | DBMET01879 | |
| 0.029 | 0.552 | 0.253 | Lipoxygenase inhibitor | 0.225 0.118 DBMET02168 0.253 0.098 DBMET02170 | DBMET02170 | |
| 0.021 | 0.545 | 0.128 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 DB12110 0.128 0.035 DBMET01878 | DBMET01878 | |
| 0.001 | 0.527 | 0.035 | Arginase inhibitor | 0.035 0.027 DBMET01879 | DBMET01879 | |
| 0.027 | 0.553 | 0.155 | Cyclooxygenase 3 inhibitor | 0.155 0.044 DB12110 0.155 0.044 DBMET01878 | DBMET01878 | |
| 0.001 | 0.527 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET01879 | DBMET01879 | |
| 0.002 | 0.53 | 0.053 | Nicotinic alpha4beta2 receptor agonist | 0.053 0.004 DB12110 0.053 0.004 DBMET01878 | DBMET01878 | |
| 0.037 | 0.565 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 DB12110 0.179 0.068 DBMET01878 0.133 0.123 DBMET02170 | DBMET01878 | |
| 0.013 | 0.543 | 0.114 | Sodium channel blocker | 0.114 0.092 DB12110 0.114 0.092 DBMET01878 | DBMET01878 | |
| 0.009 | 0.54 | 0.083 | Potassium channel (Voltage-sensitive) activator | 0.083 0.082 DB12110 0.083 0.082 DBMET01878 | DBMET01878 | |
| 0.035 | 0.568 | 0.231 | Phospholipase C inhibitor | 0.231 0.029 DB12110 0.231 0.029 DBMET01878 0.137 0.136 DBMET01879 | DBMET01878 | |
| 0.039 | 0.572 | 0.162 | CF transmembrane conductance regulator agonist | 0.162 0.057 DB12110 0.162 0.057 DBMET01878 0.149 0.078 DBMET02168 | DBMET01878 | |
| 0.007 | 0.542 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.027 DBMET01879 0.054 0.042 DBMET02169 0.059 0.036 DBMET02168 0.06 0.034 DBMET02170 | DBMET01879 | |
| 0.01 | 0.551 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.063 DB12110 0.139 0.063 DBMET01878 | DBMET01878 | |
| 0.023 | 0.564 | 0.178 | DNA methyltransferase I inhibitor | 0.143 0.111 DB12110 0.143 0.111 DBMET01878 0.178 0.081 DBMET01879 | DBMET01879 | |
| 0.001 | 0.542 | 0.034 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.034 0.015 DBMET01879 | DBMET01879 | |
| 0.016 | 0.559 | 0.152 | AMP-activated protein kinase stimulant | 0.152 0.027 DB12110 0.152 0.027 DBMET01878 | DBMET01878 | |
| 0.021 | 0.565 | 0.578 | Platelet antagonist | 0.339 0.041 DBMET02182 0.578 0.008 DBMET01879 0.305 0.051 DBMET02178 0.305 0.051 DBMET02183 0.26 0.068 DBMET02184 0.207 0.096 DBMET02173 0.326 0.045 DBMET02174 | DBMET01879 | |
| 0.026 | 0.571 | 0.125 | MAP3K9 inhibitor | 0.125 0.103 DBMET02169 | DBMET02169 | |
| 0.007 | 0.553 | 0.08 | Metalloproteinase-9 inhibitor | 0.08 0.044 DBMET02168 | DBMET02168 | |
| 0.017 | 0.564 | 0.101 | Anabolic | 0.091 0.077 DBMET02169 0.101 0.061 DBMET02168 | DBMET02168 | |
| 0.01 | 0.559 | 0.081 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET02182 0.081 0.008 DBMET01879 0.049 0.032 DBMET02178 0.049 0.032 DBMET02183 0.047 0.035 DBMET02174 | DBMET01879 | |
| 0.019 | 0.568 | 0.171 | Heat shock protein 90 alpha antagonist | 0.171 0.069 DB12110 0.171 0.069 DBMET01878 0.139 0.099 DBMET01879 | DBMET01878 | |
| 0.005 | 0.555 | 0.143 | Argininosuccinate synthase inhibitor | 0.076 0.027 DBMET02182 0.143 0.012 DBMET01879 0.074 0.028 DBMET02168 0.083 0.024 DBMET02170 0.06 0.037 DBMET02178 0.06 0.037 DBMET02183 0.079 0.026 DBMET02174 | DBMET01879 | |
| 0.045 | 0.594 | 0.719 | Toll-Like receptor 7 agonist | 0.207 0.192 DBMET02179 0.326 0.094 DBMET02169 0.719 0.008 DBMET02168 0.4 0.06 DBMET02170 0.31 0.104 DBMET02177 0.265 0.134 DBMET02178 0.265 0.134 DBMET02183 | DBMET02168 | |
| 0.023 | 0.573 | 0.136 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 DB12110 0.112 0.088 DBMET01878 0.136 0.048 DBMET01879 | DBMET01879 | |
| 0.005 | 0.555 | 0.122 | Pim-3 kinase inhibitor | 0.122 0.03 DB12110 0.122 0.03 DBMET01878 | DBMET01878 | |
| 0.003 | 0.554 | 0.054 | GP IIb/IIIa receptor antagonist | 0.054 0.03 DBMET01879 | DBMET01879 | |
| 0.005 | 0.556 | 0.193 | Phosphofructokinase-1 inhibitor | 0.11 0.028 DBMET02182 0.193 0.012 DBMET01879 0.081 0.041 DBMET02168 0.082 0.04 DBMET02178 0.082 0.04 DBMET02183 0.073 0.046 DBMET02174 | DBMET01879 | |
| 0.022 | 0.573 | 0.183 | Cyclin-dependent kinase 8 inhibitor | 0.183 0.049 DB12110 0.183 0.049 DBMET01878 | DBMET01878 | |
| 0.034 | 0.587 | 0.18 | Histone acetyltransferase inhibitor | 0.18 0.1 DBMET02174 | DBMET02174 | |
| 0.001 | 0.554 | 0.01 | Angiotensin AT2 receptor agonist | 0.01 0.008 DBMET01879 | DBMET01879 | |
| 0.077 | 0.631 | 0.234 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET02182 0.234 0.063 DBMET02169 0.233 0.064 DBMET02178 0.233 0.064 DBMET02183 | DBMET02169 | |
| 0.007 | 0.562 | 0.042 | CDK7/cyclin H inhibitor | 0.042 0.039 DBMET01879 | DBMET01879 | |
| 0.016 | 0.572 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 DB12110 0.149 0.025 DBMET01878 | DBMET01878 | |
| 0.014 | 0.57 | 0.12 | Alkaline phosphatase inhibitor | 0.12 0.086 DBMET02168 | DBMET02168 | |
| 0.018 | 0.576 | 0.091 | Glutamate (mGluR6) antagonist | 0.064 0.054 DBMET02182 0.091 0.015 DBMET01879 0.063 0.058 DBMET02178 0.063 0.058 DBMET02183 | DBMET01879 | |
| 0.005 | 0.563 | 0.059 | Cyclin A2 inhibitor | 0.059 0.048 DB12110 0.059 0.048 DBMET01878 | DBMET01878 | |
| 0.02 | 0.581 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.04 DB12110 0.054 0.04 DBMET01878 | DBMET01878 | |
| 0.002 | 0.564 | 0.055 | Nicotinic alpha3beta4 receptor agonist | 0.055 0.004 DB12110 0.055 0.004 DBMET01878 | DBMET01878 | |
| 0.021 | 0.585 | 0.362 | Platelet aggregation inhibitor | 0.362 0.024 DBMET01879 | DBMET01879 | |
| 0.004 | 0.569 | 0.065 | Pim-2 kinase inhibitor | 0.065 0.027 DB12110 0.065 0.027 DBMET01878 | DBMET01878 | |
| 0.012 | 0.578 | 0.164 | Protein kinase C mu inhibitor | 0.164 0.02 DB12110 0.164 0.02 DBMET01878 | DBMET01878 | |
| 0.018 | 0.584 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.077 DB12110 0.12 0.077 DBMET01878 0.104 0.098 DBMET01879 | DBMET01878 | |
| 0.041 | 0.607 | 0.712 | Toll-Like receptor agonist | 0.318 0.1 DBMET02169 0.712 0.008 DBMET02168 0.39 0.064 DBMET02170 0.299 0.112 DBMET02177 0.26 0.139 DBMET02178 0.26 0.139 DBMET02183 | DBMET02168 | |
| 0.005 | 0.572 | 0.184 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.093 0.04 DB12110 0.093 0.04 DBMET01878 0.184 0.015 DBMET02168 0.176 0.016 DBMET02170 | DBMET02168 | |
| 0.048 | 0.615 | 0.259 | Insulysin inhibitor | 0.196 0.164 DBMET02182 0.216 0.134 DB12110 0.216 0.134 DBMET01878 0.259 0.088 DBMET01879 | DBMET01879 | |
| 0.001 | 0.571 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 DBMET01879 | DBMET01879 | |
| 0.001 | 0.571 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 DBMET01879 | DBMET01879 | |
| 0.05 | 0.621 | 0.204 | Lipocortins synthesis antagonist | 0.182 0.069 DBMET02182 0.153 0.1 DBMET02170 0.134 0.132 DBMET02178 0.134 0.132 DBMET02183 0.204 0.054 DBMET02174 | DBMET02174 | |
| 0.005 | 0.576 | 0.055 | Cyclin A inhibitor | 0.055 0.048 DB12110 0.055 0.048 DBMET01878 | DBMET01878 | |
| 0.003 | 0.576 | 0.094 | Thromboxane A2 antagonist | 0.094 0.009 DBMET01879 | DBMET01879 | |
| 0.023 | 0.597 | 0.192 | 12-Lipoxygenase inhibitor | 0.192 0.161 DB12110 0.192 0.161 DBMET01878 | DBMET01878 | |
| 0.004 | 0.583 | 0.104 | Thromboxane antagonist | 0.104 0.01 DBMET01879 | DBMET01879 | |
| 0.003 | 0.582 | 0.063 | Sphingosine 1-phosphate receptor 1 agonist | 0.063 0.011 DBMET01879 | DBMET01879 | |
| 0.005 | 0.585 | 0.052 | Histamine H2 receptor agonist | 0.052 0.02 DBMET02168 | DBMET02168 | |
| 0.003 | 0.588 | 0.088 | Ornithine carbamoyltransferase inhibitor | 0.088 0.019 DBMET01879 0.078 0.022 DBMET02174 | DBMET01879 | |
| 0.013 | 0.598 | 0.233 | MAP kinase kinase 2 inhibitor | 0.233 0.062 DB12110 0.233 0.062 DBMET01878 | DBMET01878 | |
| 0.035 | 0.62 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 DB12110 0.124 0.064 DBMET01878 | DBMET01878 | |
| 0.019 | 0.608 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.087 DB12110 0.139 0.087 DBMET01878 | DBMET01878 | |
| 0.027 | 0.616 | 0.139 | Aurora-C kinase inhibitor | 0.139 0.066 DB12110 0.139 0.066 DBMET01878 | DBMET01878 | |
| 0.026 | 0.616 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 DB12110 0.092 0.041 DBMET01878 0.082 0.064 DBMET02170 | DBMET01878 | |
| 0.01 | 0.6 | 0.113 | Glutamate (mGluR group III) antagonist | 0.113 0.005 DBMET01879 | DBMET01879 | |
| 0.007 | 0.598 | 0.109 | Aconitate hydratase inhibitor | 0.051 0.038 DBMET02182 0.109 0.007 DBMET01879 0.047 0.045 DBMET02178 0.047 0.045 DBMET02183 | DBMET01879 | |
| 0.009 | 0.6 | 0.051 | Glutamate (mGluR8) agonist | 0.051 0.011 DBMET01879 | DBMET01879 | |
| 0.002 | 0.596 | 0.043 | Diamine oxidase inhibitor | 0.043 0.02 DB12110 0.043 0.02 DBMET01878 | DBMET01878 | |
| 0.012 | 0.606 | 0.571 | GABA C receptor agonist | 0.166 0.028 DBMET02182 0.199 0.02 DB12110 0.199 0.02 DBMET01878 0.571 0.003 DBMET01879 0.158 0.031 DBMET02168 0.125 0.046 DBMET02170 0.108 0.059 DBMET02178 0.108 0.059 DBMET02183 0.133 0.042 DBMET02174 | DBMET01879 | |
| 0.028 | 0.622 | 0.271 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.151 0.147 DBMET02182 0.271 0.034 DBMET01879 0.178 0.096 DBMET02168 | DBMET01879 | |
| 0.004 | 0.599 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.019 DBMET02169 | DBMET02169 | |
| 0.004 | 0.6 | 0.098 | Sphingosine 1-phosphate receptor agonist | 0.098 0.006 DBMET01879 | DBMET01879 | |
| 0.004 | 0.601 | 0.072 | Glutamate receptor agonist | 0.072 0.061 DBMET01879 | DBMET01879 | |
| 0.01 | 0.607 | 0.128 | Phospholipase A2 inhibitor | 0.128 0.104 DBMET01879 | DBMET01879 | |
| 0.002 | 0.603 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET01879 | DBMET01879 | |
| 0.024 | 0.625 | 0.213 | Antipruritic | 0.153 0.091 DB12110 0.153 0.091 DBMET01878 0.213 0.04 DBMET02168 0.153 0.09 DBMET02170 | DBMET02168 | |
| 0.004 | 0.609 | 0.082 | Protocollagen prolyl hydroxylase inhibitor | 0.082 0.004 DBMET01879 | DBMET01879 | |
| 0.002 | 0.608 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DB12110 0.02 0.01 DBMET01878 | DBMET01878 | |
| 0.008 | 0.617 | 0.102 | Aminopeptidase I inhibitor | 0.073 0.049 DBMET02182 0.102 0.027 DBMET01879 0.071 0.052 DBMET02174 | DBMET01879 | |
| 0.006 | 0.617 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.039 DB12110 0.069 0.039 DBMET01878 | DBMET01878 | |
| 0.017 | 0.629 | 0.147 | Interleukin 8 antagonist | 0.147 0.036 DB12110 0.147 0.036 DBMET01878 | DBMET01878 | |
| 0.007 | 0.62 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.014 DB12110 0.062 0.014 DBMET01878 | DBMET01878 | |
| 0.003 | 0.617 | 0.112 | Aromatase inhibitor | 0.112 0.019 DBMET01879 | DBMET01879 | |
| 0.003 | 0.619 | 0.101 | Bombesin 3 receptor agonist | 0.101 0.003 DBMET02168 0.091 0.004 DBMET02170 | DBMET02168 | |
| 0.007 | 0.624 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.014 DB12110 0.065 0.014 DBMET01878 | DBMET01878 | |
| 0.009 | 0.628 | 0.117 | Polo-like kinase-4 inhibitor | 0.117 0.059 DB12110 0.117 0.059 DBMET01878 | DBMET01878 | |
| 0.008 | 0.627 | 0.116 | MAP kinase 8 inhibitor | 0.116 0.046 DBMET02168 0.115 0.047 DBMET02170 | DBMET02168 | |
| 0.067 | 0.687 | 0.27 | Interleukin 2 agonist | 0.232 0.14 DBMET02182 0.25 0.118 DBMET01879 0.27 0.098 DBMET02178 0.27 0.098 DBMET02183 0.217 0.161 DBMET02174 | DBMET02183 | |
| 0.014 | 0.636 | 0.296 | Alpha-N-acetylglucosaminidase inhibitor | 0.164 0.048 DBMET02182 0.148 0.056 DB12110 0.148 0.056 DBMET01878 0.296 0.017 DBMET01879 0.184 0.039 DBMET02169 0.197 0.035 DBMET02168 0.182 0.04 DBMET02170 0.157 0.051 DBMET02178 0.157 0.051 DBMET02183 0.147 0.056 DBMET02174 | DBMET01879 | |
| 0.009 | 0.64 | 0.221 | Aryl hydrocarbon receptor agonist | 0.221 0.092 DB12110 0.221 0.092 DBMET01878 | DBMET01878 | |
| 0.004 | 0.635 | 0.085 | Neutrophil collagenase inhibitor | 0.085 0.029 DBMET02168 0.065 0.044 DBMET02170 | DBMET02168 | |
| 0.012 | 0.645 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.023 DB12110 0.058 0.023 DBMET01878 | DBMET01878 | |
| 0.002 | 0.635 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.017 DBMET01879 | DBMET01879 | |
| 0.001 | 0.635 | 0.022 | Cyclin T1 inhibitor | 0.022 0.009 DB12110 0.022 0.009 DBMET01878 | DBMET01878 | |
| 0.008 | 0.643 | 0.093 | MAP kinase kinase 1 inhibitor | 0.093 0.066 DB12110 0.093 0.066 DBMET01878 | DBMET01878 | |
| 0.028 | 0.664 | 0.204 | Immunosuppressant | 0.204 0.193 DBMET01879 | DBMET01879 | |
| 0.005 | 0.642 | 0.074 | Metalloproteinase-2 inhibitor | 0.074 0.059 DBMET02168 | DBMET02168 | |
| 0.003 | 0.641 | 0.121 | Bombesin agonist | 0.121 0.004 DBMET02168 0.108 0.004 DBMET02170 | DBMET02168 | |
| 0.021 | 0.661 | 0.097 | Photosensitizer | 0.097 0.094 DBMET01879 | DBMET01879 | |
| 0.014 | 0.655 | 0.19 | Bone formation stimulant | 0.19 0.039 DBMET01879 | DBMET01879 | |
| 0.023 | 0.67 | 0.135 | Glutamate (mGluR7) agonist | 0.096 0.069 DB12110 0.096 0.069 DBMET01878 0.135 0.019 DBMET01879 | DBMET01879 | |
| 0.005 | 0.653 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 DB12110 0.103 0.06 DBMET01878 | DBMET01878 | |
| 0.012 | 0.664 | 0.121 | Cyclin-dependent kinase 7 inhibitor | 0.121 0.084 DB12110 0.121 0.084 DBMET01878 | DBMET01878 | |
| 0.007 | 0.659 | 0.187 | Abl kinase inhibitor | 0.16 0.043 DBMET02179 0.187 0.031 DBMET02177 | DBMET02177 | |
| 0.007 | 0.66 | 0.188 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.16 0.043 DBMET02179 0.188 0.031 DBMET02177 | DBMET02177 | |
| 0.008 | 0.666 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.054 DB12110 0.059 0.054 DBMET01878 | DBMET01878 | |
| 0.004 | 0.665 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.044 DBMET02168 | DBMET02168 | |
| 0.005 | 0.667 | 0.072 | MAP kinase 10 inhibitor | 0.072 0.061 DBMET02168 | DBMET02168 | |
| 0.008 | 0.67 | 0.058 | Bombesin antagonist | 0.058 0.02 DBMET02168 0.053 0.025 DBMET02170 | DBMET02168 | |
| 0.005 | 0.667 | 0.045 | Carbonic anhydrase I stimulant | 0.045 0.02 DBMET01879 | DBMET01879 | |
| 0.011 | 0.674 | 0.335 | M18 aspartyl aminopeptidase inhibitor | 0.335 0.009 DBMET01879 | DBMET01879 | |
| 0.005 | 0.67 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 DB12110 0.082 0.059 DBMET01878 | DBMET01878 | |
| 0.011 | 0.677 | 0.149 | Insulin sensitizer | 0.149 0.135 DBMET01879 | DBMET01879 | |
| 0.008 | 0.676 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 DB12110 0.057 0.042 DBMET01878 | DBMET01878 | |
| 0.007 | 0.675 | 0.103 | Protein kinase C delta inhibitor | 0.103 0.05 DB12110 0.103 0.05 DBMET01878 | DBMET01878 | |
| 0.02 | 0.689 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 DB12110 0.101 0.086 DBMET01878 | DBMET01878 | |
| 0.005 | 0.674 | 0.04 | Membrane dipeptidase inhibitor | 0.04 0.027 DBMET01879 0.036 0.034 DBMET02178 0.036 0.034 DBMET02183 | DBMET01879 | |
| 0.005 | 0.678 | 0.036 | Integrin alpha2 antagonist | 0.036 0.026 DB12110 0.036 0.026 DBMET01878 | DBMET01878 | |
| 0.005 | 0.679 | 0.082 | Phenylalanine 4-hydroxylase inhibitor | 0.082 0.036 DBMET01879 | DBMET01879 | |
| 0.011 | 0.685 | 0.181 | I kappa B kinase epsilon inhibitor | 0.181 0.088 DB12110 0.181 0.088 DBMET01878 | DBMET01878 | |
| 0.059 | 0.736 | 0.222 | Nitric-oxide synthase stimulant | 0.222 0.058 DB12110 0.222 0.058 DBMET01878 0.197 0.093 DBMET02168 0.207 0.077 DBMET02170 | DBMET01878 | |
| 0 | 0.678 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.005 DBMET01879 | DBMET01879 | |
| 0.01 | 0.69 | 0.134 | MAP-kinase-activated kinase inhibitor | 0.134 0.02 DB12110 0.134 0.02 DBMET01878 | DBMET01878 | |
| 0.004 | 0.686 | 0.033 | AMPA receptor agonist | 0.033 0.029 DBMET01879 | DBMET01879 | |
| 0.004 | 0.687 | 0.088 | Collagenase 3 inhibitor | 0.088 0.02 DBMET02168 0.062 0.039 DBMET02170 | DBMET02168 | |
| 0.005 | 0.69 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.051 DB12110 0.107 0.051 DBMET01878 | DBMET01878 | |
| 0.009 | 0.695 | 0.114 | Interleukin 1 beta converting enzyme inhibitor | 0.114 0.041 DBMET01879 | DBMET01879 | |
| 0.007 | 0.694 | 0.087 | Potassium channel activator | 0.087 0.064 DB12110 0.087 0.064 DBMET01878 | DBMET01878 | |
| 0.006 | 0.694 | 0.103 | Carbonic anhydrase stimulant | 0.103 0.018 DBMET01879 0.057 0.044 DBMET02168 | DBMET01879 | |
| 0.006 | 0.693 | 0.15 | LIM domain kinase 1 inhibitor | 0.15 0.098 DB12110 0.15 0.098 DBMET01878 | DBMET01878 | |
| 0.008 | 0.697 | 0.12 | MAP-kinase-activated kinase 2 inhibitor | 0.12 0.02 DB12110 0.12 0.02 DBMET01878 | DBMET01878 | |
| 0.003 | 0.693 | 0.046 | Thymidylate synthase inhibitor | 0.046 0.033 DBMET02168 | DBMET02168 | |
| 0.021 | 0.712 | 0.248 | Antibacterial | 0.238 0.189 DB12110 0.238 0.189 DBMET01878 0.239 0.187 DBMET01879 0.248 0.179 DBMET02169 | DBMET02169 | |
| 0.015 | 0.711 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 DB12110 0.091 0.023 DBMET01878 | DBMET01878 | |
| 0.036 | 0.736 | 0.191 | Growth hormone agonist | 0.161 0.079 DBMET02182 0.191 0.062 DBMET01879 0.128 0.11 DBMET02178 0.128 0.11 DBMET02183 0.171 0.072 DBMET02174 | DBMET01879 | |
| 0.015 | 0.716 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.038 DBMET02170 0.08 0.075 DBMET02173 | DBMET02170 | |
| 0.003 | 0.709 | 0.075 | Nav1.7 sodium channel blocker | 0.075 0.038 DB12110 0.075 0.038 DBMET01878 | DBMET01878 | |
| 0.017 | 0.726 | 0.119 | Nav1.4 sodium channel blocker | 0.114 0.058 DBMET02169 0.119 0.052 DBMET02178 0.119 0.052 DBMET02183 | DBMET02183 | |
| 0.007 | 0.719 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.048 DB12110 0.059 0.048 DBMET01878 | DBMET01878 | |
| 0.006 | 0.722 | 0.162 | MAP kinase 9 inhibitor | 0.162 0.033 DBMET02168 0.132 0.044 DBMET02170 | DBMET02168 | |
| 0.001 | 0.722 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 DB12110 0.02 0.011 DBMET01878 | DBMET01878 | |
| 0.006 | 0.728 | 0.051 | AICAR transformylase inhibitor | 0.051 0.021 DBMET01879 | DBMET01879 | |
| 0.005 | 0.729 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 DB12110 0.087 0.083 DBMET01878 | DBMET01878 | |
| 0.017 | 0.745 | 0.273 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 DB12110 0.273 0.081 DBMET01878 | DBMET01878 | |
| 0.003 | 0.739 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET01879 | DBMET01879 | |
| 0.013 | 0.751 | 0.063 | Carbonic anhydrase II stimulant | 0.063 0.02 DBMET01879 | DBMET01879 | |
| 0.005 | 0.767 | 0.077 | I kappa B kinase inhibitor | 0.077 0.064 DB12110 0.077 0.064 DBMET01878 | DBMET01878 | |
| 0.002 | 0.772 | 0.022 | Estrone sulfatase inhibitor | 0.022 0.015 DBMET01879 | DBMET01879 | |
| 0.005 | 0.777 | 0.077 | Neuraminidase (influenza) inhibitor | 0.077 0.028 DBMET02169 | DBMET02169 | |
| 0.006 | 0.786 | 0.078 | Plasminogen activator inhibitor | 0.078 0.027 DBMET01879 | DBMET01879 | |
| 0.005 | 0.79 | 0.094 | Mucolytic | 0.094 0.087 DBMET02174 | DBMET02174 | |
| 0.012 | 0.808 | 0.181 | Transcription factor STAT inhibitor | 0.181 0.166 DB12110 0.181 0.166 DBMET01878 | DBMET01878 | |
| 0.004 | 0.811 | 0.057 | Glutamate (mGluR group III) agonist | 0.057 0.02 DBMET01879 | DBMET01879 | |
| 0.03 | 0.837 | 0.302 | Sodium/bile acid cotransporter inhibitor | 0.286 0.092 DBMET02182 0.302 0.077 DBMET01879 0.275 0.103 DBMET02178 0.275 0.103 DBMET02183 0.245 0.133 DBMET02174 | DBMET01879 | |
| 0.007 | 0.815 | 0.107 | Caspase 3 inhibitor | 0.107 0.079 DBMET01879 | DBMET01879 | |
| 0.004 | 0.812 | 0.142 | Cyclin-dependent kinase 5 inhibitor | 0.133 0.05 DBMET02168 0.142 0.045 DBMET02170 | DBMET02170 | |
| 0.012 | 0.83 | 0.222 | Bombesin 3 receptor antagonist | 0.076 0.021 DBMET02169 0.222 0.001 DBMET02168 0.217 0.001 DBMET02170 | DBMET02168 | |
| 0.002 | 0.831 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 DBMET01879 | DBMET01879 | |
| 0.01 | 0.849 | 0.298 | Angiogenesis inhibitor | 0.298 0.094 DBMET02168 | DBMET02168 | |
| 0.005 | 0.847 | 0.16 | Anticoagulant | 0.16 0.072 DBMET02168 | DBMET02168 | |
| 0.008 | 0.859 | 0.141 | Hemostatic | 0.137 0.085 DBMET01879 0.141 0.08 DBMET02168 0.127 0.1 DBMET02170 | DBMET02168 | |
| 0.008 | 0.898 | 0.087 | Somatostatin 1 agonist | 0.087 0.044 DBMET02169 0.069 0.066 DBMET02178 0.069 0.066 DBMET02183 | DBMET02169 | |
| 0.004 | 0.895 | 0.084 | Factor VIIa inhibitor | 0.083 0.013 DBMET02168 0.084 0.013 DBMET02170 | DBMET02170 | |
| 0.048 | 0.941 | 0.438 | Calcium channel L-type activator | 0.438 0.057 DBMET02169 0.24 0.217 DBMET02176 0.367 0.105 DBMET02178 0.367 0.105 DBMET02183 | DBMET02169 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |